abdullah's picture
Add files using upload-large-folder tool
8de7e09 verified
1
00:00:02,230 --> 00:00:06,830
ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ู†ู„ุชู‚ู‰ ุงู„ูŠูˆู… ููŠ ู…ุญุงุถุฑุฉ ุฌุฏูŠุฏุฉ
2
00:00:06,830 --> 00:00:12,230
ุนู†ูˆุงู† cytokine ูˆูƒู…ุง ุชุนู„ู…ูˆู† ุงู„ cytokine ู‡ูŠ ุนุจุงุฑุฉ ุนู†
3
00:00:12,230 --> 00:00:15,610
ุฌู„ูŠูƒูˆ ุจุฑูˆุชูŠู† substance which has low molecular
4
00:00:15,610 --> 00:00:20,540
weightูˆุงู†ุชุฌุช ู…ู† ุฎู„ุงุฆูŠ ู…ู† ู†ูุณู‡ุง ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง
5
00:00:20,540 --> 00:00:21,140
ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง
6
00:00:21,140 --> 00:00:27,000
ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง
7
00:00:27,000 --> 00:00:27,180
ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง
8
00:00:27,180 --> 00:00:27,200
ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง
9
00:00:27,200 --> 00:00:29,080
ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง ูˆุงู†ุชุฌุช ู…ู† ู†ูุณู‡ุง
10
00:00:29,080 --> 00:00:33,080
ูˆุงู†ุชุฌุช
11
00:00:33,080 --> 00:00:45,940
ู…ู† ู†ูุณู‡ุง ูˆุงู†ุช
12
00:00:46,220 --> 00:00:51,100
ูŠุนู†ูŠ ุจุชู†ู‚ู„ ุฑุณุงุฆู„ ู…ุง ุจูŠู† ุงู„ุฎู„ุงูŠุง ููŠ ุงู„ immune
13
00:00:51,100 --> 00:00:56,800
system it's also regulated by particular cytokine
14
00:00:56,800 --> 00:01:03,800
receptor ูŠุนู†ูŠ ู„ุงุฒู… ุงู„ cytokine ุนุดุงู† ูŠุดุชุบู„ ูŠูƒูˆู† ู„ู‡
15
00:01:03,800 --> 00:01:11,440
receptor for that factor cytokine ุฃูŠุถุง produced by
16
00:01:11,440 --> 00:01:16,620
lymphocyte ุจูŠุณู…ูˆู‡ุง lymphokineูˆุงู„ู„ูŠ ุจุชู†ุชุฌ ู…ู† ุงู„ู€
17
00:01:16,620 --> 00:01:22,260
Monocyte ุฃูˆ ุงู„ู€ Macrophage ุจูŠุณู…ูˆู‡ุง Monokines ูˆ
18
00:01:22,260 --> 00:01:29,880
ุฃูŠุถู‹ุง ุจุชุณู…ู‰ Chemokine ูŠูˆู… ู…ุง ุชุดุชุบู„ as a
19
00:01:29,880 --> 00:01:33,840
chemotactic factor Chemotactic factor ูŠุนู†ูŠ ู‡ูŠ
20
00:01:33,840 --> 00:01:38,880
ุนุจุงุฑุฉ ุนู† factors ุจุชุณุงุนุฏ ููŠ ุนู…ู„ูŠุฉ ุญุฑูƒุฉ ุงู„ุฎู„ูŠุฉ
21
00:01:38,880 --> 00:01:47,200
ุจุงุชุฌุงู‡ ุงู„ุงู†ุชุฌู† these factorsู†ุญู† ู„ุณู†ุง ู…ุฌุฑุฏ ู†ูˆุน ู…ู†
22
00:01:47,200 --> 00:01:49,340
ุงู„ุงู†ููˆุณุงูŠุช ู†ุญู† ู„ุณู†ุง ู…ุฌุฑุฏ ู†ูˆุน ู…ู† ุงู„ุงู†ููˆุณุงูŠุช ู†ุญู†
23
00:01:49,340 --> 00:01:49,360
ู„ุณู†ุง ู…ุฌุฑุฏ ู†ูˆุน ู…ู† ุงู„ุงู†ููˆุณุงูŠุช ู†ุญู† ู„ุณู†ุง ู…ุฌุฑุฏ ู†ูˆุน ู…ู†
24
00:01:49,360 --> 00:01:51,880
ุงู„ุงู†ููˆุณุงูŠุช ู†ุญู† ู„ุณู†ุง ู…ุฌุฑุฏ ู†ูˆุน ู…ู† ุงู„ุงู†ููˆุณุงูŠุช ู†ุญู†
25
00:01:51,880 --> 00:01:56,940
ู„ุณู†ุง ู…ุฌุฑุฏ ู†ูˆุน ู…ู† ุงู„ุงู†ููˆุณุงูŠุช ู†ุญู† ู„ุณู†ุง ู…ุฌุฑุฏ ู†ูˆุน ู…ู†
26
00:01:56,940 --> 00:02:01,880
ุงู„ุงู†ููˆุณุงูŠุช ู†ุญู† ู„ุณู†ุง ู…ุฌุฑุฏ ู†ูˆุน ู…ู† ุงู„ุงู†ููˆุณุงูŠุช ู†ุญู†
27
00:02:01,880 --> 00:02:04,020
ู„ุณู†ุง ู…ุฌุฑุฏ ู†ูˆุน ู…ู† ุงู„ุงู†ููˆุณุงูŠุช ู†ุญู† ู„ุณู†ุง ู…ุฌุฑุฏ ู†ูˆุน ู…ู†
28
00:02:04,020 --> 00:02:09,540
ุงู„ุงู†ููˆุณุงูŠุช ู†ุญู† ู„ุณู†ุง ู…ุฌุฑุฏ ู†ูˆุน ู…ู† ุงู„ุงู†ููˆุณุงูŠุช ู†ุญู†
29
00:02:09,540 --> 00:02:12,710
ู„ุณู†ุง ู…ุฌุฑุฏ ู†ูˆุน ู…ู† ุงู„ุงู†ูˆุงู†ุง it's a generic name ูŠุนู†ูŠ
30
00:02:12,710 --> 00:02:22,110
ุงุณู… ุนุงู… for these placaridins ุงูŠุถุง ุณู…ูˆู‡ู…
31
00:02:22,110 --> 00:02:26,550
Interleukins ู„ุฅู† ู‡ู…ุง ูŠุชุนุงู…ู„ูˆู† ุจูŠู† ุนูŠูˆู† ุจูŠู†
32
00:02:26,550 --> 00:02:28,750
ุงู„ู„ูˆูƒูˆุณูŠุงุช Interleukin
33
00:02:33,290 --> 00:02:37,250
ุงู„ูŠูˆู… ุงุนุฏุงุฏู‡ู… ุทุจุนุง ุงุนุทูˆู‡ู… ุงุฑู‚ุงู… ูˆ ุงู„ุงุฑู‚ุงู… ูˆุตู„ุช
34
00:02:37,250 --> 00:02:40,710
ุงูƒุชุฑ ู…ู† ุชู„ุงุชูŠู† different interlocus are present
35
00:02:40,710 --> 00:02:45,990
macro phase ุงูŠุถุง derived ุงูˆ ุจูŠุณู…ูˆู‡ู… lymphocyte
36
00:02:45,990 --> 00:02:50,710
activating factor ูˆ ู‡ูŠ T cell growth factors
37
00:02:50,710 --> 00:02:55,910
ูุงุนุทูˆู‡ู… ุงูŠุดุŸ ุงุนุทูˆู‡ู… ุงุฑู‚ุงู… ุฒูŠ ู…ุง ู‚ู„ู†ุง IL-1 ูˆ IL-2
38
00:02:55,910 --> 00:03:01,690
they can activate macro phase and T lymphocyte
39
00:03:01,690 --> 00:03:06,110
respectivelyุงู„ูŠูˆู… ุฒูŠ ู…ุง ู‚ู„ู†ุง ููŠ ุงูƒุชุฑ ู…ู† ุชู„ุงุชูŠู†
40
00:03:06,110 --> 00:03:12,270
different Interleukins are coined ู…ุนุธู…ู‡ู… are
41
00:03:12,270 --> 00:03:17,130
biological biologically affect many cell types
42
00:03:17,130 --> 00:03:22,790
ุฏุงุฎู„ ูˆ ุฎุงุฑุฌ ุงู„ immune system ูุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„
43
00:03:22,790 --> 00:03:30,290
Interleukin 2promote cell proliferation and also
44
00:03:30,290 --> 00:03:37,090
stimulate osteoclast ูˆุงุญุฏ ุชุงู†ูŠ transforming growth
45
00:03:37,090 --> 00:03:41,070
factor beta ุจุณู…ูˆู‡
46
00:03:41,070 --> 00:03:43,770
transforming growth factor beta ูˆ ุจุณู…ูˆู‡ tumor
47
00:03:43,770 --> 00:03:48,730
growth factor beta ุงูŠุถุง stimulate many cells ุจู…ุง
48
00:03:48,730 --> 00:03:52,990
ููŠู‡ุง ุงู„ tissue fibroblast ูˆุจุงู„ุชุงู„ูŠ
49
00:03:54,190 --> 00:03:58,130
ุฃูˆ D-lymphocyte ูˆB-lymphocyte ูˆุจุงู„ุชุงู„ูŠ ู‡ุคู„ุงุก ุงู„ู€
50
00:03:58,130 --> 00:04:04,010
cytokines ุจู…ุนู†ู‰ ุจู„ุงูŠูˆุชุฑูˆุจูŠูƒูŠ ุจู…ุนู†ู‰ ุจู„ุงูŠูˆุชุฑูˆุจูŠูƒูŠ
51
00:04:04,010 --> 00:04:08,370
ุจู…ุนู†ู‰ ููŠู‡ู… ูˆุธุงุฆู ู…ุชุนุฏุฏุฉ ู„ุฃู†ู‡ู… ูŠู…ูƒู†ูˆุง ุฃู† ูŠุคุซุฑูˆุง
52
00:04:08,370 --> 00:04:10,890
ุนู…ู„ูŠุฉ ุงู„ุนุฏูŠุฏ ู…ู† ุงู„ุฎู„ู‚ุงุช
53
00:04:13,850 --> 00:04:18,470
ู‡ู†ุงูƒ ุฃูŠุถู‹ุง ู…ู† ุตูุงุชู‡ู… ุงู„ุฑูŠุฏุงู†ุฏู†ุณูŠุฉ ุงู† ู‡ู…ุง ุฑูŠุฏุงู†ุฏู†ุช
54
00:04:18,470 --> 00:04:25,090
ุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ุงูŠ ุงู†ุช ุงู„ู„ูˆูƒู† ุชูˆุช ุงูˆ ุงู†ุช ุงู„ู„ูˆูƒู†
55
00:04:25,090 --> 00:04:31,930
ููˆุฑ ูŠู…ูƒู† ุงู† ูŠุนู…ู„ูˆุง ูƒุชุณู„ ุงุฌุฑุงุซ ูุงูƒุชูˆุฑุงุช ุชุงู†ูŠุฉ
56
00:04:31,930 --> 00:04:36,770
ุจูŠุดุชุบู„ูˆุง ุนู„ู‰ ุชูŠู„ูŠู…ููˆุณุงูŠุช ูˆูŠุดุชุบู„ูˆุง ููŠ ุงุฌุฑุงุซู‡ุง ุนุดุงู†
57
00:04:36,770 --> 00:04:38,390
ู‡ูŠูƒ ุจูŠุณู…ูˆู‡ู… ุฑูŠุฏุงู†ุฏู†ุช
58
00:04:43,750 --> 00:04:48,730
ูˆCytokine ุงู„ู„ูŠ ู‡ู… ุงูŠุถุง ุตูุงุช ุงู„ุงุฏุงุชูŠู ูŠุนู†ูŠ ุงุชู†ูŠู†
59
00:04:48,730 --> 00:04:55,190
ู…ู…ูƒู† ู†ุดุชุบู„ู‡ synergistic or antagonistic they are
60
00:04:55,190 --> 00:05:01,730
properties ู…ู† ุงู„ุตูุงุช ุงู„ุนุงู…ุฉ ู„ู„cytokine A they have
61
00:05:01,730 --> 00:05:06,070
common functional properties ูˆุฎุฏูˆุง ุงู„ุฃู…ุซู„ุฉ ุนู„ู‰ ุฐู„ูƒ
62
00:05:06,070 --> 00:05:10,690
common functional properties cytokineุจุนุถ ุงู„ู€
63
00:05:10,690 --> 00:05:13,830
cytokines ู…ุซู„ ุงู„ู€ Gamma Interferon ูˆ ุงู„ู€
64
00:05:13,830 --> 00:05:21,470
Interleukin 2 ุงู„ุชู†ูŠู† ู…ูƒุณูˆุฑุฉ ุจุงู„ุณู„ุณู„ ูˆ ู…ูƒุณูˆุฑุฉ ุจุณุฑุนุฉ
65
00:05:21,470 --> 00:05:24,670
ุตูุฉ
66
00:05:24,670 --> 00:05:33,210
ุฃุฎุฑู‰ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ
67
00:05:33,210 --> 00:05:35,330
ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ
68
00:05:35,330 --> 00:05:36,450
ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ
69
00:05:36,450 --> 00:05:36,570
ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ ู…ุฎุชู„ูุฉ
70
00:05:36,570 --> 00:05:40,860
ู…ุฎุชู„ูุฉ ู…ุฎุชู…ุนุธู… ุงู„ู€ cytokines ูŠู…ุชู„ุฆูˆู† ุญูŠุงุฉ ู‚ุตูŠุฑุฉ ุฃูˆ
71
00:05:40,860 --> 00:05:47,940
ู†ุตู ูˆ ุงู„ู€ function of the cytokines occur in pairs
72
00:05:47,940 --> 00:05:52,340
ุจูŠุตู†ุนูˆุง
73
00:05:52,340 --> 00:05:57,200
ูˆ ุจูŠุดุชุบู„ูˆุง ูƒุงู†ูุฌุงุฑ ู…ุฑุฉ ูˆุงุญุฏุฉ ู‡ูƒุฐุง ุงู„ cytokines
74
00:05:57,200 --> 00:05:59,460
facilitate communication between cells
75
00:06:03,570 --> 00:06:12,610
ูˆู‡ูŠ ุจุชุฑูƒูŠุฒู‡ู… ุฅู„ู‰ ุนุดุฑุฉ ู‚ูˆุฉ ู…ุงู†ุณ ุชู† ู„ู„ุนุดุฑุฉ ู‚ูˆุฉ ู…ุงู†ุณ
76
00:06:12,610 --> 00:06:20,110
ููุชูŠู† ุงูŠุถุง ูŠู…ูƒู† ุงู† ูŠุนู…ู„ูˆุง ูƒู‡ุฑู…ูˆู† ูŠู…ูƒู† ุงู† ูŠูƒูˆู†ูˆุง
77
00:06:20,110 --> 00:06:26,850
ู…ูุฑุฏูŠู† ูƒ Autocrine ุงูˆ Paracrine ุงูˆ EndocrineุฃูŠุถู‹ุง
78
00:06:26,850 --> 00:06:31,790
ู…ู† ูˆุธุงุฆูู‡ู… ุฃูˆ ุตูุงุชู‡ู… ุณุฑูŠุนู‹ุง ุงู„ู€Cytokine ูŠู…ูƒู† ุฃู†
79
00:06:31,790 --> 00:06:35,590
ุชุนู…ู„ ุชุฃุซูŠุฑ ุนู…ู„ูŠุฉ ู„ู‡ู… ู…ู† ุฎู„ุงู„ ุงุฑุชุจุงุทู‡ู… ุจู…ุฌู…ูˆุนุงุช
80
00:06:35,590 --> 00:06:42,190
ู…ุญุฏุฏุฉ ูุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ุชุญูุฒ ุฃูˆ ุงู†ู‡ูŠุจ ุชุงุฑุฌุช ุณูŠู„ ู…ุซู„
81
00:06:42,190 --> 00:06:49,030
T-Helper-1 ูŠูˆู… ู…ุง ุชูุฑุฒ Gamma Interferon ุชู†ุดุท
82
00:06:49,030 --> 00:06:52,550
ุงู„ู…ูŠูƒุฑูˆูุงุฌ ูˆููŠ ู†ูุณ ุงู„ูˆู‚ุช ุชุนู…ู„ ุงู†ู‡ูŠุจุดูŠู†
83
00:06:52,550 --> 00:06:58,840
ู„ู„ู…ูŠู„ูŠู…ููˆุณุงูŠุชูŠุนู†ูŠ ู†ูุณ ุงู„ grammar interferon
84
00:06:58,840 --> 00:07:04,560
activate macrophage and inhibit B lymphocytes ู†ูุณ
85
00:07:04,560 --> 00:07:10,300
ุงู„ุญูƒุงูŠุฉ ููŠ ุชูŠู„ ุจุงุฑุชูˆ ูŠูˆู… ู…ุง ุชูุฑุฒ ุงู„ I L4 ูˆ I L5
86
00:07:10,300 --> 00:07:18,350
they activate B lymphocytes and I L10ุฃูŠุถู‹ุง ุจูŠูุฑุฒ
87
00:07:18,350 --> 00:07:23,950
ุงู†ู‡ูŠุจุช ุงู„ macro phase activation ูˆู‡ุฐุง ุนุจุงุฑุฉ ุจูŠุณู…ูˆู‡
88
00:07:23,950 --> 00:07:28,330
ู‡ุฐุง ุนู…ู„ูŠุฉ ุงู„ regulation ู…ุง ุจูŠู† ุงู„ู„ูŠ ู‡ูˆ ุชูƒูˆูŠู† T
89
00:07:28,330 --> 00:07:32,910
helper ูˆุงุญุฏ ุฃูˆ T helper ุงุชู†ูŠู† ู…ุง ูŠุคุซุฑ ููŠ ุฐู„ูƒ ู‡ูˆ ุงู„
90
00:07:32,910 --> 00:07:39,750
type of antigen ูˆู‡ุฐู‡ ุงู„ููŠุฌุฑ ู‡ูŠ T helper ูˆุงุญุฏ 100%
91
00:07:39,750 --> 00:07:50,700
antigen ุชู„ู‚ูุชู‡ ุงู„ู„ูŠ ู‡ูˆ ุงู„Dendritic cell ููŠ ุฃูุฑุฒ IL
92
00:07:50,700 --> 00:07:56,440
-12 ุญูˆู„ุช ุชูŠู‡ูŠู„ุจุฑ ู†ูˆุฏ ุงู„ู‰ ุชูŠู‡ูŠู„ุจุฑ ูˆู† ู†ุดุทุฉ ุชูŠู‡ูŠู„ุจุฑ
93
00:07:56,440 --> 00:07:58,700
ู†ูˆุฏ ุงู„ู‰ ุชูŠู‡ูŠู„ุจุฑ ู†ูˆุฏ ุงู„ู‰ ุชูŠู‡ูŠู„ุจุฑ ู†ูˆุฏ ุงู„ู‰ ุชูŠู‡ูŠู„ุจุฑ
94
00:07:58,700 --> 00:08:06,440
ู†ูˆุฏ ุงู„ู‰ ุชูŠู‡ูŠู„ุจุฑ ู†ูˆุฏ ุงู„ู‰ ุชูŠู‡ูŠู„ุจุฑ ู†ูˆุฏ ุงู„ู‰ ุชูŠู‡ูŠู„ุจุฑ
95
00:08:06,440 --> 00:08:11,780
ู†ูˆุฏ ุงู„ู‰ ุชูŠู‡ูŠู„ุจุฑ ู†ูˆุฏุฅูุฑุงุฒ ุทุจุนุง cytokine ุฏูŠ ุงู„ site
96
00:08:11,780 --> 00:08:15,460
ุทุจุนุง ููŠู‡ุง ุงู„ activation ุฅุฌุช ู†ุดุทุช ุงู„ macro phase ู…ู†
97
00:08:15,460 --> 00:08:19,160
ุฎู„ุงู„ ุงุฑุชุจุงุทู‡ุง ููŠู‡ุง cell to cell contact ูˆ ุฃูุฑุฒู‡ุง
98
00:08:19,160 --> 00:08:23,060
ุงู„ cytokine ุฅูŠุด ุงู„ cytokine ุฃูุฑุฒุชู‡ุงุŸ ุฌู…ุน
99
00:08:23,060 --> 00:08:29,280
ุงู„terferon ู†ุดุท ุงู„ macro phase GMCSF ู†ุดุท macro
100
00:08:29,280 --> 00:08:33,440
phase tumor necrosis factor alpha ู†ุดุท macro phase
101
00:08:33,440 --> 00:08:39,860
IL3 ุนู…ู„ hemopoiesisTuber Necrosis Factor Beta
102
00:08:39,860 --> 00:08:48,200
ุฃูŠุถู‹ุง ูŠูุฑุฒ ุฃุซู†ุงุก ุงู„ู€ Inflammatory Reaction ูุงู„ู…ุฌุงู„
103
00:08:48,200 --> 00:08:54,300
ู‡ุฐุง ุชูŠุงู„ุจุฑ ูˆุงุญุฏ ุจุชู†ุดุท microphage ูˆ ุทุจุนู‹ุง ู‡ู†ุดูˆู ูˆ
104
00:08:54,300 --> 00:08:57,940
ุจู†ุนุฑู ุฃู† ูˆุธูŠูุฉ ุงู„ microphage ููŠู‡ุง ุณุช ูˆุธุงุฆู ู…ุฎุชู„ูุฉ
105
00:08:57,940 --> 00:09:03,660
ุจุณ ุฃู‡ู… ูˆุธูŠูุฉ ู‡ูŠ ุงู„ูู„ุณูุชูˆุณูŠุณ ููŠ ุงู„ู…ู‚ุงุจู„ ุชูŠุงู„ุจุฑ 2 ุฏู‡
106
00:09:03,660 --> 00:09:09,290
ู‡ูŠ ูŠูˆู… ุงุชุตุงุฏู AntigenDendritic cell ุจุชู‚ุฏู… ู„ู‡ุง T
107
00:09:09,290 --> 00:09:14,710
helper node ุจุนุฏ ู…ุง ุชูุฑุฒ I L 4 ูˆ T helper node
108
00:09:14,710 --> 00:09:19,270
ุชุชุญูˆู„ ู„ T helper 2 ุงู„ู„ูŠ ู‡ูŠ ุจุชู†ุดุท ุจูŠ ู„ู…ููˆุณุงูŠุชุฑ ุทุงุจุช
109
00:09:19,270 --> 00:09:23,250
ููŠ ุจูŠ ู„ู…ููˆุณุงูŠุชุฑ ู‡ูŠ ุงู„ binding ูˆ ุจุชูุฑุฒ cytokine ุดูˆ
110
00:09:23,250 --> 00:09:29,790
ุงู„ cytokine ุจุชูุฑุฒู‡ุง I L 4 ุจู†ุดุท ุจูŠ ุณู„ I L 5 ุจู†ุดุท ุจูŠ
111
00:09:29,790 --> 00:09:34,750
ุณู„ I L 10 ุจูŠุนู…ู„ ุงู† ู‡ูŠ ุจุดูŠู„ ู„ T helper 1 ู…ู† ุฎู„ุงู„ ุงู†
112
00:09:34,750 --> 00:09:40,370
ู‡ูŠ ุจุดูŠู„ ู„ ุงู„ microfilmุนูŠุงู„ ุชู„ุงุชุฉ ู‡ูŠู…ูˆุจูŠูƒุณูŠ ุนูŠุงู„
113
00:09:40,370 --> 00:09:46,290
ุชู„ุงุชุฉ ุนูŠุงู„
114
00:09:46,290 --> 00:09:50,910
ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ
115
00:09:50,910 --> 00:09:51,230
ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„
116
00:09:51,230 --> 00:09:54,070
ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ
117
00:09:54,070 --> 00:09:54,110
ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ
118
00:09:54,110 --> 00:09:55,590
ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ ุนูŠุงู„
119
00:09:55,590 --> 00:10:02,650
ุชู„ุงุชุฉ ุนูŠุงู„ ุชู„ุงุชุฉ
120
00:10:05,840 --> 00:10:11,840
ุงู„ุฎุฑูˆุฌ ู…ู† ุงู„ุฎู„ุงูŠุง
121
00:10:11,840 --> 00:10:17,180
ุงู„ุชูŠ ุชู†ุดุทุช ุจูˆุงุณุทุฉ ุงู„ุงู†ุชูŠุฌูŠู† ุจูŠุฃุชูŠ ุงู„ู‰ ู†ุดุงุท ู…ุฎุชู„ู
122
00:10:17,180 --> 00:10:24,220
ู…ุฎุชู„ู ุงู„ู„ูŠ ู‡ูˆ cell typeูŠูˆู… ู…ุง ู†ูุฑุฒ ุงู„ู€ cytokine
123
00:10:24,220 --> 00:10:28,220
ุนู„ู‰ ู…ุณุชูˆู‰ ุนุงู„ูŠ ูŠูƒูˆู† ู„ุฏูŠู‡ู… ุฅุณุชู…ูˆู„ุงุช ู‚ูˆูŠุฉ ูˆ ูŠู…ูƒู† ุฃู†
124
00:10:28,220 --> 00:10:33,800
ูŠุคุซุฑ ุนู„ูŠู‡ุง ุฅูุนุงู„ุฉ ุฏู„ูŠู„ูŠุฉ ูˆ ุฅูุนุงู„ุฉ ุณูŠุณุชุงู…ูŠุฉ ู…ุซู„ ู…ุง
125
00:10:33,800 --> 00:10:38,260
ูŠุณู…ู‰ ุจู€ toxic shock syndrome ุงู„ู€ cytokine ู„ุงุฒู…
126
00:10:38,260 --> 00:10:44,620
ูŠูุฑุฒู‡ ุจุชุฑูƒูŠุฒ ู‚ู„ูŠู„ ุฌุฏุง ู„ูƒู† ูŠูˆู… ู…ุง ูŠูƒูˆู† ุชุฑูƒูŠุฒู‡ ูุฑุฒู‡
127
00:10:44,620 --> 00:10:51,400
ุจูƒู…ูŠุงุช ุนุงู„ูŠุฉ ุฌุฏุง ุนุงู„ูŠุฉ ุงู„ุชุฑูƒูŠุฒ ุจุณุจุจ ุชุฃุซูŠุฑุงุช ู…ุคุฐูŠุฉ
128
00:10:51,930 --> 00:10:56,670
Deleterious ุบูŠุฑ ู…ููŠุฏุฉ ู…ุคุฐูŠุฉ ู…ุงุดูŠุฉ and systemic
129
00:10:56,670 --> 00:11:03,490
ูŠุนู†ูŠ ุนุงู…ุฉ ูˆ ุฒูŠ ู…ุง ุจูŠุตูŠุฑ ููŠ ุญุงู„ุฉ ุงู„ toxic shock
130
00:11:03,490 --> 00:11:08,750
syndrome ู‡ู†ุดูˆูู‡ุง ุงู† ุดุงุก ุงู„ู„ู‡ ู‚ุฏุงู… ููŠ ุงู„ diseases
131
00:11:08,750 --> 00:11:13,710
therapeutic manipulation ูƒู…ุงู† ู…ู…ูƒู† ุงุญู†ุง ู†ู„ุนุจ ุจุงู„
132
00:11:13,710 --> 00:11:17,690
cytokine ู…ู† ู†ุงุญูŠุฉ ุงู„ู„ูŠุฑูŠุฉ ู†ุณุชููŠุฏ ู…ู†ู‡ู… ู…ู† ู†ุงุญูŠุฉ ุฅูŠุด
133
00:11:17,950 --> 00:11:24,170
ุฅู„ุงุฌูŠุฉ ุฃูŠุถุง ููŠ ูŠุนู†ูŠ ุงู„ุชู„ุงุนุจ ููŠ ุงู„ู„ูŠ ู‡ูˆ ุงู„ immune
134
00:11:24,170 --> 00:11:28,010
system ุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ if we use the component
135
00:11:28,010 --> 00:11:34,890
ุงู„ู„ูŠ ู‡ูˆ cytokine we can activate if we use the
136
00:11:34,890 --> 00:11:39,430
cytokine antagonist we can inhibit ูˆ ู„ุง ูƒุฐุง
137
00:11:39,820 --> 00:11:45,100
ุจุฅู…ูƒุงู†ู†ุง ุชุญุฑูŠูƒ ู†ุธุงู… ุงู„ุญูŠูˆุงู†ุงุช ุจุงุณุชุฎุฏุงู… ู‡ุฐู‡ ุงู„ู€
138
00:11:45,100 --> 00:11:51,860
cytokine ุทูŠุจ ู…ุง ู‡ูŠ ุงู„ุฎู„ุงูŠุง ุงู„ู„ู‰ ู…ู…ูƒู† ุชูุฑุฒู„ู†ุง ุงู„ู„ู‰
139
00:11:51,860 --> 00:11:59,820
ู‡ูˆ cytokine in a cascade manner ุทุจุนุง
140
00:11:59,820 --> 00:12:03,180
ููŠ ุฎู„ุงูŠุง given cell ู…ู…ูƒู† ุชุนู…ู„ ูƒุซูŠุฑ ู…ู† ุงู„ cytokine
141
00:12:05,570 --> 00:12:09,390
One cell may be the target of many cytokines ุทุจูŠุนูŠ
142
00:12:09,390 --> 00:12:14,210
ุฌุฏุง ุฎู„ูŠุฉ ูˆุงุญุฏุฉ ู…ู…ูƒู† ูŠูƒูˆู† ุงูƒุชุฑ ู…ู† ุงู„ cytokine
143
00:12:14,210 --> 00:12:18,010
ุจูŠุดุชุบู„ ุนู„ูŠู‡ุง ูˆูƒู„ ูˆุงุญุฏ ุจุฑุชุจุท ุงู„ receptor ุนู„ู‰ ุณุทุญ
144
00:12:18,010 --> 00:12:24,730
ู‡ุฐู‡ ุงู„ุฎู„ูŠุฉ ูƒู…ุงู† one cytokine ู…ู…ูƒู† ูŠุฃุซุฑ ุนู„ู‰ ุชุฃุซูŠุฑ
145
00:12:24,730 --> 00:12:29,250
ุฃูˆ ูŠุฃุซุฑ ุนู„ู‰ ุงู„ู„ูŠ ู‡ูˆ ูุนู„ูŠุฉ ุงู„ other cytokine
146
00:12:30,700 --> 00:12:37,620
ูˆุจุงู„ุชุงู„ูŠ ู…ู…ูƒู† ูŠุนู†ูŠ ูŠุถูŠู ู„ู‡ function ู…ุงุดูŠ ุฃูˆ ูŠุถูŠู
147
00:12:37,620 --> 00:12:42,940
ูŠู‚ูˆูŠ ุงู„ function ูŠุนู†ูŠ additive or synergistic or
148
00:12:42,940 --> 00:12:47,500
antagonistic interaction
149
00:12:47,500 --> 00:12:50,380
of multiple cytokines produced during typical
150
00:12:50,380 --> 00:12:55,490
immune responseุฃูŠุถู‹ุง ุจูŠุณู…ูˆู‡ุง ุงู„ู„ูŠ ู‡ูˆ cytokine
151
00:12:55,490 --> 00:13:00,910
cascade and this cascade largely determine whether
152
00:13:00,910 --> 00:13:05,530
a response to an antigen will primarily antibody
153
00:13:05,530 --> 00:13:09,890
-mediated or cell-mediated ูŠุนู†ูŠ ุงู„ interaction ู„ู…ุง
154
00:13:09,890 --> 00:13:13,790
ุชูุฑุฒ ุฃูƒุชุฑ ู…ู† cytokine they interact to each other
155
00:13:14,070 --> 00:13:19,370
ู‡ู… ูŠุณู…ูˆู†ู‡ุง ูƒู€ Cytokine Cascade ูˆู‡ุฐุง ุงู„ู€ Cascade
156
00:13:19,370 --> 00:13:25,550
ุงู„ู…ุญุตู„ ุฃู† ู‡ูŠ ุชุจุนุชู‡ ูŠุง ุฅู…ุง ุจูŠูƒูˆู† ู„ู†ุง Antibody ุฃูˆ
157
00:13:25,550 --> 00:13:29,030
ุจู†ุดุท ู„ู†ุง ุฎู„ุงูŠุง ู…ู†ุงุนูŠุฉ ูุงุนู„ุฉ
158
00:13:31,990 --> 00:13:35,910
ุงู„ุนู…ู„ ุงู„ู…ู‡ู… ููŠ ู‡ุฐู‡ ุงู„ุนู…ู„ูŠุฉ ู‡ูˆ ุงู„ู€ Antigenic
159
00:13:35,910 --> 00:13:41,490
Stimulus ู‡ูˆ ุงู„ู€ Antigen ู…ู† ูŠุญุฏุฏ ุฎุท ุณูŠุฑ ุฃูˆ ู†ู‡ุงูŠุฉ
160
00:13:41,490 --> 00:13:49,050
ุงู„ู„ูŠ ู‡ูˆ ู†ุดุงุท ุงู„ู€ cytokine ุทูŠุจุŒ
161
00:13:49,050 --> 00:13:51,330
ุงู„ receptor ู„ู„ cytokine ุทุจุนุงุŒ they have common
162
00:13:51,330 --> 00:13:55,690
receptorุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ุงู†ุง ู‚ู„ู†ุง ุงู†ู‡ ููŠู‡
163
00:13:55,690 --> 00:13:58,650
overlapping ูŠุนู†ูŠ ููŠู‡ redundant function ุนู„ู‰ ุณุจูŠู„
164
00:13:58,650 --> 00:14:02,510
ุงู„ู…ุซุงู„ ุงูŠุฉ ุงู„ูˆุงุญุฏ ูˆุงูŠุฉ ุงู„ุณุชุฉ ู…ู…ูƒู† both ูƒุงู†ุช both
165
00:14:02,510 --> 00:14:06,370
induce fever ูˆูŠุจู‚ู‰ ู„ู‡ู… ุทุจุนุง different biological
166
00:14:06,370 --> 00:14:10,010
function ุฃุฎุฑู‰
167
00:14:12,760 --> 00:14:15,760
ูˆุงุฌู‡ุชู‡ ุงู† ุงู„ู€Signal Cytokine ูŠุณุชุฎุฏู… ู…ุฑุชูุนุงุช
168
00:14:15,760 --> 00:14:20,260
ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช
169
00:14:20,260 --> 00:14:21,640
ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช
170
00:14:21,640 --> 00:14:21,780
ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช
171
00:14:21,780 --> 00:14:23,600
ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช
172
00:14:23,600 --> 00:14:24,980
ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช
173
00:14:24,980 --> 00:14:25,040
ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช
174
00:14:25,040 --> 00:14:30,420
ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช ู…ุฑุชูุนุงุช
175
00:14:30,420 --> 00:14:35,200
ู…ุฑุชูุนุงุช
176
00:14:35,200 --> 00:14:36,580
ู…
177
00:14:39,560 --> 00:14:43,140
ูˆู‡ูŠ ู‡ุฐู‡ ุงู„ู€ Common Gamma Chain ู‡ูŠ ุงู„ู…ุณุคูˆู„ุฉ ุนู†
178
00:14:43,140 --> 00:14:48,120
Signal Transduction ุฃูˆ ุงู„ู€ Chemical Messenger ู…ุง
179
00:14:48,120 --> 00:14:51,740
ุฃุญู†ุง ุณู…ูŠู†ุงู‡ Chemical Messenger ูˆุจุงู„ุชุงู„ูŠ ุจูŠุฑุณู„ูˆุง
180
00:14:51,740 --> 00:14:56,800
ุฑุณุงู„ุฉ ุฅู„ู‰ ุงู„ุฏุงุฎู„ ูˆุจุงู„ุชุงู„ูŠ ู‡ู… ุงู„ู…ุณุคูˆู„ูŠู† ู‡ุฐู‡ ุงู„ู€
181
00:14:56,800 --> 00:14:59,240
Chain ู‡ูŠ ุงู„ู…ุณุคูˆู„ุฉ ุนู† ุงู„ู€ Intracellular Signaling
182
00:14:59,240 --> 00:15:06,500
Molecule ูˆู‡ุฐุง ุจูŠูุณุฑ ู„ู†ุง ู„ูŠุด ุงู† ููŠ ุฃูƒุชุฑ ู…ู† ุงู„ู„ูŠ ู‡ูˆ
183
00:15:06,500 --> 00:15:14,280
cytokine can act on theirSame Cell ูƒู…ุง ุชุดุงู‡ุฏูˆู† ููŠ
184
00:15:14,280 --> 00:15:20,380
ุงู„ููŠุฌุฑ ุงู„ู‰ 6 ุงูŠ ููŠู‡ ุงูƒุชุฑ ู…ู† Receptors ูƒู„ู‡ู… They
185
00:15:20,380 --> 00:15:26,040
Share ุงู„ู„ูŠ ู‡ูˆ Gamma Chain ููŠู‡ Triple Chain ููŠู‡
186
00:15:26,040 --> 00:15:30,660
Double Chain ุงู„ู…ู‡ู… ูƒู„ู‡ู… ูŠุญุชูˆูˆุง ุนู„ู‰ Gamma Chain ูˆ
187
00:15:30,660 --> 00:15:33,840
Gamma Chain ู‡ูŠ ุงู„ู…ุณุคูˆู„ุฉ ุนู† ุฅูŠู‡ุนู† ุงู„ู„ูŠ ู‡ูˆ Signal
188
00:15:33,840 --> 00:15:37,780
Transduction ู„ุฃู†ู‡ุง ูˆุงุญุฏุฉ ู„ูƒู„ ุงู„ู€ Receptors ุงู„ู„ูŠ
189
00:15:37,780 --> 00:15:41,480
ู…ูˆุฌูˆุฏุฉ ูŠุจู‚ู‰ ุบุงู„ุจุง ุงู„ signal ู‡ูŠ ูˆุงุญุฏุฉ ุนุดุงู† ู‡ูŠูƒ
190
00:15:41,480 --> 00:15:47,660
ุจู†ู„ุงู‚ูŠ ููŠ multiple cytokine can have the same ุงู„ู„ูŠ
191
00:15:47,660 --> 00:15:53,200
ู‡ูˆ function functional category ุจุณ ุทุจุนุง ู‚ุณู…ูˆุง ู‡ุฐุง
192
00:15:53,200 --> 00:15:57,960
ุงู„ cytokine ุฅู„ู‰ different category ุฌุงู„ูˆุง cytokine
193
00:15:57,960 --> 00:16:00,320
that regulate immune response ุชุดุชุฑ ุนู„ู‰ ุงู„ immune
194
00:16:00,320 --> 00:16:03,890
responseูˆุทุจุนุง ุฃู‡ู… ููŠ ู‡ุฐู‡ ุงู„ุฎู„ุงูŠุง ู‡ูŠ ุงู„ B ูˆ T
195
00:16:03,890 --> 00:16:10,210
lymphocyte activity ูŠูˆู… ูŠุชุนุฑุถูˆุง ู„ antigen ูŠูˆู… ูŠุดูŠุฑ
196
00:16:10,210 --> 00:16:13,720
ู„ู‡ู… stimulation by antigenู‡ุคู„ุงุก ุงู„ู€ cytokines
197
00:16:13,720 --> 00:16:20,440
ูŠุนู…ู„ูˆู† ุจุดูƒู„ ุฃุณุงุณูŠ ุนู„ู‰ ุงู„ุงู†ุชุฌูŠู† ุงู„ู…ุดุบูˆู„ ู„ู„ู…ููˆุณุงูŠุชูŠู†
198
00:16:20,440 --> 00:16:26,540
ู…ุซุงู„ ุนู„ู‰ ุฐู„ูƒ CD4T ู„ู„ู…ููˆุณุงูŠุชูŠู† ุจุชุนุชุจุฑ ู…ุตุงุฏุฑ ูƒุจูŠุฑุฉ
199
00:16:26,540 --> 00:16:30,320
ู„ู„ุฅูŠู…ูŠู†ูˆ ุฑุงุฌู„ุงุชุฑูŠ ู„ู„ู€ cytokine ูŠุนู†ูŠ ุจุนุฏ ู…ุง ุชุชู†ุดุท
200
00:16:30,320 --> 00:16:34,840
ุจุชูุฑุฒู„ู†ุง cytokine ุงู„ู„ูŠ ุจุชุนู…ู„ ุฑุงุฌู„ุงุชูŠ ู„ู„ุฅูŠู…ูŠู†ูˆ
201
00:16:34,840 --> 00:16:43,610
ุฑุงุฌู„ุงุชุฑูŠู†ุงูŠูŠู CD4 ู†ูุณ ุงู„ู€ T-Lymphocyte ุงู„ู„ูŠ ู‡ูŠ ุงู„ู€
202
00:16:43,610 --> 00:16:49,110
T-cell ุงู„ู„ูŠ ู„ู… ุชุตุงุฏู ุฃู†ุชุฌูŠู† ุจุนุฏ ุฃูˆู„ ู…ุฑุฉ ุจุชุดูˆูู‡
203
00:16:49,110 --> 00:16:53,970
ูƒุงู†ุช ู…ุฎุชู„ูุฉ ุฅู„ู‰ ู…ุฌู…ูˆุนุงุช ูˆู…ู…ูƒู† ุชุตู†ุน ู…ุฎุชู„ูุฉ ุชู‚ุฑูŠุจุง
204
00:16:53,970 --> 00:16:55,650
ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง
205
00:16:55,650 --> 00:16:57,670
ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง
206
00:16:57,670 --> 00:16:59,390
ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง
207
00:16:59,390 --> 00:17:00,790
ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠุจุง ุชู‚ุฑูŠ
208
00:17:04,440 --> 00:17:06,900
ุฃูŠุถู‹ุงุŒ ุงู„ูƒุซูŠุฑ ู…ู† ุงู„ุจูƒุชูŠุฑูŠุง ุงู„ุงู†ุชุฑุงุซูŠุฉ ู…ุซู„
209
00:17:06,900 --> 00:17:10,740
ุงู„ุงุณุชูŠุฑูŠุง ูˆุงู„ููŠุฑูˆุณ ุจู†ุดุทูˆุง ุงู„ู€ Dendritic cell ูˆ
210
00:17:10,740 --> 00:17:14,280
ุจู†ุดุทูˆุง ุงู„ู€ macrophage ูˆ ุจู†ุดุทูˆุง ุงู„ู€ NK cell ูƒู„ู‡ู…
211
00:17:14,280 --> 00:17:17,740
ูŠู…ูƒู† ุฃู† ูŠู†ุชุฌูˆุง ุงู„ู€ IL-12 ูˆ Gamma Interferon
212
00:17:17,740 --> 00:17:23,340
ูˆุทุจุนู‹ุงุŒ ู‡ุฐุง ุฒูŠ ู…ุง ุดูู†ุง ููŠ ุงู„ููŠุฌูˆุฑ 11.6 ู‡ุคู„ุงุก ูŠู…ูƒู†
213
00:17:23,340 --> 00:17:27,860
ุฃู† ูŠุทู„ุนูˆุง ุนู„ู‰ ุงู„ู€ cytokine ุงู„ุชูŠ ุชู†ุชุฌ ุชูŠู‡ูŠู„ุจุฑ 1 ู…ู†
214
00:17:27,860 --> 00:17:34,730
ู…ู† ุชูŠู‡ูŠู„ุจุฑู†ูˆุช ุชูŠู‡ูŠู„ุจุฑู†ูˆุช ุนุจุงุฑุฉ ุนู†ุฎู„ูŠุฉ ุงู„ุจุฑูˆุฌูŠู†ูŠุชุฑ
215
00:17:34,730 --> 00:17:38,410
ุชูŠู„ูŠููˆุณุงูŠุชุณ ุงู„ู„ู‰ ุงุชู†ุดุทุช ูˆุฏุชู†ูŠ ูˆุตู„ู‡ุง
216
00:17:38,410 --> 00:17:42,250
differentiation ูˆุงุชู†ุดุทุช ูˆุฏุชู†ูŠ ุงู…ุง ุชูŠุงู„ุจุฑ ูˆุงุญุฏ ูˆุงู…ุง
217
00:17:42,250 --> 00:17:46,830
ุชูŠุงู„ุจุฑ ุงุชู†ูŠู† ุดูˆูู†ุง ู‡ุฐุง ููŠ ุงู„ุงุด ููŠ ุงู„ figure ุงู„ุณุงุจู‚
218
00:17:46,830 --> 00:17:52,250
other pathogens ุฒู‰ ุงู„ worms ุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ุจูŠุคุฏูˆุง
219
00:17:52,250 --> 00:17:59,030
ุฅู„ู‰ ุงู„ secretion of IL-5 ุจูˆุงุณุทุฉ ุงู„ู…ุตู„ ุนู„ู‰ ุณุจูŠู„
220
00:17:59,030 --> 00:18:07,780
ุงู„ู…ุซุงู„ ุงู„ IL-4 ุฃูŠุถุงูˆู‡ุฐุง ูŠู†ูุฐ ุชุทุจูŠู‚ ุงู„ุจุฑู†ูˆุฏ ุงู„ู‰
221
00:18:07,780 --> 00:18:12,980
ุชู‡ูŠู„ุจุฑุชูˆ ู†ูุณ ุงู„ุดูŠุก ุงู„ู„ู‰ ุดูู†ุงู‡ ููŠ ุงู„ููŠุฌุฑ ุงู„ู„ู‰ ูุงุช
222
00:18:12,980 --> 00:18:17,900
ูˆู‡ุฐุง ุชูุณูŠุฑ ู„ุฐู„ูƒ ุงูŠุถุง low level ุงูˆ processed
223
00:18:17,900 --> 00:18:27,780
antigen ูƒู…ูŠุฉ ู‚ู„ูŠู„ุฉ ุชุชุนุงู…ู„ ู…ุน ุชู‡ูŠู„ุจุฑุชูˆ TCR ูˆุจุณ
224
00:18:27,780 --> 00:18:34,160
ุชุฑุชุจุท ุจู‡ุฐู‡ ุงู„ูƒู…ูŠุฉ ุงู„ู‚ู„ูŠู„ุฉ ุชุฎุชุงุฑ ุชู‡ูŠู„ุจุฑุชูˆูˆูˆุฌุฏู‡ุง
225
00:18:34,160 --> 00:18:40,360
ุชูุฑุฒ IL-4 ูˆ IL-5 ูŠูˆู… ุชุฒูŠุฏ ุงู„ูƒู…ูŠุฉ increase level
226
00:18:40,360 --> 00:18:45,800
ุงู„ู„ูŠ ุจุชุทุจู‚ ุจุชุจุฏุฃ ุชู‡ูŠู„ุจุฑ ู†ูˆุช TCR ุจุชุฃุฏูŠ ุงู„ู‰
227
00:18:45,800 --> 00:18:50,300
differentiation into ุชู‡ูŠู„ุจุฑ one ูˆุจุงู„ุชุงู„ูŠ ูˆุฌุฏู‡ุง
228
00:18:50,300 --> 00:18:54,400
ุชู‡ูŠู„ุจุฑ one ุจุชุตูŠุฑ ุฎุงู†ูŠุฉ ู†ุงุฏุฑุฉ ุชุณุชุทูŠุน ุงู† ุชูุฑุฒ IL-2
229
00:18:54,400 --> 00:18:57,740
ูˆGamma Interferon ูˆTumor Necrosis Factor Beta
230
00:18:59,250 --> 00:19:03,870
Pathway of Tl-bar-1 ูŠุณู‡ู‘ู„
231
00:19:03,870 --> 00:19:07,610
ุงู„ู€ cell-mediated immunity ุจุงูƒุชูุงุก ุงู„ู€ macrophage
232
00:19:07,610 --> 00:19:13,810
ุนู† ูƒูŠุณ ุงู„ู€ cytotoxic T-lymphocyte ุจูŠู†ู…ุง Tl-bar-2
233
00:19:13,810 --> 00:19:17,730
ุจุงุซูˆูŠุฉ ุฃุณุงุณูŠุฉ ู„ุฅูŠุฌุงุจ ุงู„ู€ immunity ุงู„ู‡ูˆ ุฅู†ุชุงุฌ
234
00:19:17,730 --> 00:19:22,490
ุงู„ุงู†ุชูŠุจุงุฏูŠูŠุนู†ูŠ ุชูŠู‡ูŠู„ุจุฑ 1 ุจูŠุฏูŠู†ุง cell mediated
235
00:19:22,490 --> 00:19:27,010
ุจูŠู†ู…ุง ุชูŠู‡ูŠู„ุจุฑ 2 ุจูŠุฏูŠู†ุง antibody mediated immunity
236
00:19:27,010 --> 00:19:34,290
ูˆุจุงู„ุชุงู„ูŠ ุชูŠู‡ูŠู„ุจุฑ subset also can regulate the
237
00:19:34,290 --> 00:19:38,310
growth and effector function of each other as a
238
00:19:38,310 --> 00:19:42,030
result of the activity of cytokine ุชู†ุชูŠู† ุดูˆูู†ุง ูƒูŠู
239
00:19:42,030 --> 00:19:45,430
ุจูŠุนู…ู„ูˆุง regulation to each other ู…ู† ุฎู„ุงู„ ุงู„
240
00:19:45,430 --> 00:19:46,990
cytokine that they release
241
00:19:49,640 --> 00:19:52,320
ุงู„ู€ IL-10 ุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ุงู„ู€ Transformed Growth
242
00:19:52,320 --> 00:19:56,460
Factor Beta ุงู„ู„ูŠ ุชุทู„ุน ู…ู† T helper 2 ูŠู…ูƒู† ุงู†ู‡ูŠุจุท
243
00:19:56,460 --> 00:20:03,400
ุงู†ู‡ูŠุจุท ุงู†ู‡ูŠุจุท ุชุทูˆุฑ T helper 1 ูˆูŠูˆู… ู…ุง ูŠุณูŠุฑ ููŠู‡
244
00:20:03,400 --> 00:20:07,300
ุงูุฑุงุฒ ู„ู€ Gamma Interferon ู…ู† T helper 1 ูŠู…ูƒู†
245
00:20:07,300 --> 00:20:12,280
ุงู†ู‡ูŠุจุท ุงู†ู‡ูŠุจุท ุชุทูˆุฑ T helper 2 ูŠุจู‚ู‰ Cytokine ุชู‚ุฏุฑ
246
00:20:12,280 --> 00:20:15,620
ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ
247
00:20:15,620 --> 00:20:17,680
ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ
248
00:20:17,680 --> 00:20:18,590
ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชู‚ุฏุฑ ุชูƒูˆ
249
00:20:18,590 --> 00:20:22,730
ุณูŠู„ ุชุฑุฌุน ุงู„ู‰ ู…ูˆู‚ุน ูƒูˆูŠุณุงู†ุช ูŠุนู†ูŠ ุชูุฑุฏ ุงู„ู€ cytokine
250
00:20:22,730 --> 00:20:29,250
ุชู†ุดุท ู‡ุฐู‡ ุงู„ุฎู„ุงูŠุง ุซู… ุจุงู†ุชู‡ุงุก ุงู„ุงู†ุชุฌูŠู† ุชุฑุฌุน ุงู„ู‰
251
00:20:29,250 --> 00:20:35,530
ูˆุถุนู‡ุง ุงู„ุทุจูŠุนูŠ ูู‡ู…ุด cytokine ุงู„ู†ูˆุน ุงู„ุชุงู†ูŠ ู…ู† ุงู„
252
00:20:35,530 --> 00:20:42,570
cytokine that facilitate immune innate immune
253
00:20:42,570 --> 00:20:47,200
response and activate inflammatory responseุฃู†ุง
254
00:20:47,200 --> 00:20:54,800
ุจุฏุฃุด ู†ุญูƒูŠ ุนู„ู‰ ุฅูŠุด ุนู„ู‰ ุงู„ู„ูŠ ู‡ูˆ ุงู„ T
255
00:20:54,800 --> 00:20:59,480
and cell subset ู†ุญูƒูŠ ุนู„ู‰ innate immune response
256
00:20:59,480 --> 00:21:03,720
ุจุดูƒู„ ุนุงู… ูˆ activation of inflammatory response
257
00:21:03,720 --> 00:21:09,920
ู†ุจุฏุฃ ููŠ ุงู„ุฃูˆู„ ููŠ ุงู„ innate immune responseูˆ ุงู„
258
00:21:09,920 --> 00:21:17,320
cytokine ุงู„ู„ู‰ ู…ูˆุฌูˆุฏุฉ ููŠ ู‡ุฐุง ุงูˆ ุงู„ .. that
259
00:21:17,320 --> 00:21:21,740
facilitate innate immune response it's usually
260
00:21:21,740 --> 00:21:26,780
stimulated by viruses or microbial pathogenู‡ูˆ ุนู„ู‰
261
00:21:26,780 --> 00:21:29,060
ุณุจูŠู„ ุงู„ู…ุซุงู„ ุงูŠุงู„ ูˆุงุญุฏ ูˆุงูŠุงู„ ุณุชุฉ ุงูŠุงู„ ูˆุงุญุฏ ูˆุงูŠุงู„
262
00:21:29,060 --> 00:21:33,580
ุณุชุฉ ุงูŠุงู„
263
00:21:33,580 --> 00:21:38,460
ูˆุงุญุฏ ูˆุงูŠุงู„ ุณุชุฉ ุงูŠุงู„ ูˆุงุญุฏ ูˆุงูŠุงู„ ุณุชุฉ ุงูŠุงู„ ูˆุงุญุฏ ูˆุงูŠุงู„
264
00:21:38,460 --> 00:21:43,400
ุณุชุฉ ุงูŠุงู„ ูˆุงุญุฏ ูˆุงูŠุงู„ ุณุชุฉ ุงูŠุงู„ ูˆุงุญุฏ ูˆุงูŠุงู„ ุณุชุฉ ุงูŠุงู„
265
00:21:43,400 --> 00:21:44,120
ูˆุงุญุฏ ูˆุงูŠุงู„ ุณุชุฉ ุงูŠุงู„ ูˆุงุญุฏ ูˆุงูŠุงู„ ุณุชุฉ ุงูŠุงู„ ูˆุงุญุฏ ูˆุงูŠุงู„
266
00:21:44,120 --> 00:21:44,520
ุณุชุฉ ุงูŠุงู„ ูˆุงุญุฏ ูˆุงูŠุงู„ ุณุชุฉ ุงูŠุงู„ ูˆุงุญุฏ ูˆุงูŠุงู„ ุณุชุฉ ุงูŠุงู„
267
00:21:44,520 --> 00:21:50,560
ูˆุงุญุฏ ูˆุงูŠุงู„ ุณุชุฉ ุงูŠุงู„ ูˆุงุญุฏ ูˆุงูŠุงู„ ุณุชุฉ ุงูŠุงู„ ูˆุงุญุฏ ูˆ
268
00:21:51,490 --> 00:21:55,070
ู†ู…ุฑ ุงุชู†ูŠู† They stimulate the production of acute
269
00:21:55,070 --> 00:21:57,870
phase protein ุดูˆ ุจูŠุนู…ู„ acute phase protein ุนู„ู‰
270
00:21:57,870 --> 00:22:02,550
ู…ุซุงู„ ุนู„ู‰ ุฐู„ูƒ ุงู„ู„ูŠ ู‡ูˆ CRP ู„ุฃู†ู‡ ุจุฑุชุจุท ุจุงู„ููˆุณููˆุฑูŠ
271
00:22:02,550 --> 00:22:06,850
ุงู„ูƒูˆู„ูŠู† ุชุจุน ุงู„ bacterial cell membrane or surface
272
00:22:07,990 --> 00:22:14,050
ูˆุจุงู„ุชุงู„ูŠ ุจูŠุนู„ู‘ู… ุงู„ุจูƒุชูŠุฑูŠุง ุจุฃู†ู‡ุง ุชุนู…ู„ ูƒู€ Optional
273
00:22:14,050 --> 00:22:18,610
ูˆู…ุชู‰ ู…ุชุนู„ู‘ู…ุฉ ุชุชู†ุดุท ุทุจุนุง ููŠ ู†ูุณ ุงู„ูˆู‚ุช ุชุชู†ุดุท ุงู„ู„ูŠ ู‡ูˆ
274
00:22:18,610 --> 00:22:22,530
ุจูŠุตูŠุฑ ููŠู‡ Antibody Complex ูˆุจุชุชู†ุดุท ุงู„ classical
275
00:22:22,530 --> 00:22:27,950
pathway of the complement ู†ูˆุน ุชุงู†ูŠ ู…ู† ุงู„ acute
276
00:22:27,950 --> 00:22:32,360
phase ุฒูŠ ุงู„ู…ู†ูˆุณ binding ู„ูƒุชูŠู† ุฃูŠุถุงุจุฑุชุจุท ุจุงู„ู€
277
00:22:32,360 --> 00:22:35,340
Mannose ุงู„ู„ู‰ ู…ูˆุฌูˆุฏุฉ ุนู„ู‰ ุณุทุญ ุงู„ุจูƒุชูŠุฑูŠุง ูˆุจุดุชุบู„ as
278
00:22:35,340 --> 00:22:40,040
obstinate ูˆุจู†ุดุฑุฉ complement ุฃูŠุถู‹ุง they increase
279
00:22:40,040 --> 00:22:43,500
the number of circulating neutrophil ู…ุทู„ูˆุจุฉ ููŠู‡
280
00:22:43,500 --> 00:22:48,240
ุงู„ู„ู‰ ู‡ูˆ ุณุงุญุฉ ุงู„ู…ุนุฑูƒุฉ during inflammation ุฃูŠุถู‹ุง
281
00:22:48,240 --> 00:22:55,000
they can activate Enkei cell ู†ูˆุน
282
00:22:55,000 --> 00:22:58,520
ุชุงู†ูŠ ู…ู† ุงู„ู€ cytokines ุงู„ interferon Alpha ูˆ Beta
283
00:22:59,070 --> 00:23:04,010
ุจุฅู…ูƒุงู†ู‡ู… ุงู† ูŠูƒูˆู†ูˆุง ู…ุฑุชุจุทูŠู† ุจู…ุฌู…ูˆุนุงุช ูƒุซูŠุฑุฉ ุจุนุฏ
284
00:23:04,010 --> 00:23:10,950
ู…ุง ูŠุญุตู„ ููŠู‡ ู…ุตุงุจุฉ ููŠุฑูˆุณูŠุฉ ูˆ ุจุฅู…ูƒุงู†ู‡ู… ุงู† ูŠุญุทู…ูˆุง
285
00:23:10,950 --> 00:23:18,670
ู…ุฌู…ูˆุนุงุช ุงู„ููŠุฑูˆุณ ูˆ ุจูŠู…ู†ุนูˆุง ุงู„ู„ูŠ ู‡ูˆ ุฅุตุงุจุฉ ุงู„ุฎู„ุงูŠุง
286
00:23:18,670 --> 00:23:25,210
ุงู„ุณู„ูŠู…ุฉ ุจุงู„ููŠุฑูˆุณ ู‡ุฐู‡ ุงู„ู€ cytokine ุชุฑููŠุฑูˆู† Alpha ูˆ
287
00:23:25,210 --> 00:23:30,160
Betaู…ุงุฐุง ูุนู„ูˆู‡ุŸ ู‚ุงู„ูˆุง ุงู†ู‡ู… ู‚ู…ูˆุง ุจุฅุถุงูุฉ ุงู„ู€ MSC
288
00:23:30,160 --> 00:23:35,640
Class I Expression ุนู„ู‰ ุณุทุญ ุงู„ุฎู„ุงูŠุง ุงู„ุบูŠุฑ ู…ุตุงุจุฉ
289
00:23:35,640 --> 00:23:42,540
ูˆุจุงู„ุชุงู„ูŠ ุจูŠุคุฏูŠ ุงู„ู‰ Making a Newly Infected Cell
290
00:23:44,910 --> 00:23:49,130
ุฎู„ุงุต ุชุชู…ูŠุฒ ุงู„ุฎู„ุงูŠุง ุงู„ู…ุตุงุจุฉ ู…ุง ุฒุงู„ ุฒูˆุฏู†ุง ุงู„ู„ู‰ ู‡ูˆ ุงู„
291
00:23:49,130 --> 00:23:52,710
expression of MSC class one ุนู„ู‰ ุณุทุญ ุงู„ุฎู„ุงูŠุง ุงู„ุบูŠุฑ
292
00:23:52,710 --> 00:23:57,850
ู…ุตุงุจุฉ ุจุชุตูŠุฑ ุงู„ุฎู„ุงูŠุง ุงู„ู…ุตุงุจุฉ ู…ู…ูŠุฒุฉ ูุจุชุชู†ุดุท ุงู„
293
00:23:57,850 --> 00:24:02,350
cytotoxic telephosites ูˆ ุจุชุฎู„ุตู†ุง ู…ู†ู‡ุง ุงู„ gamma
294
00:24:02,350 --> 00:24:06,690
interferon ุงู„ู„ู‰ ุจู†ุญูƒูŠ ุนู„ู‰ Alpha ูˆ Beta ุงู„ gamma
295
00:24:06,690 --> 00:24:12,250
interferon ุจุชูุฑุฒ ู…ู† ุงู„ Anky cell and other
296
00:24:12,250 --> 00:24:16,730
effectors cell ุทุจุนุงูˆุจุชุนู…ู„ induction ู„ู€ adaptive
297
00:24:16,730 --> 00:24:21,910
immune responses ู†ุดูˆู
298
00:24:21,910 --> 00:24:26,930
inflammatory cytokine ุดูู†ุง ุงู„ innate cytokine ุงู„
299
00:24:26,930 --> 00:24:31,090
inflammatory cytokine activate inflammatory cell ูˆ
300
00:24:31,090 --> 00:24:34,910
ู‡ูŠ ุจูŠุณู…ูˆู‡ู… pro-inflammatory cytokine ูˆ ู‡ูŠ ู…ุซุงู„
301
00:24:34,910 --> 00:24:38,070
ุนู„ูŠู‡ู… ุขูŠุฉ 1 ูˆ 6 ูˆ tumor necrosis factor ุฒูŠ ู…ุง
302
00:24:38,070 --> 00:24:41,490
ุดูู†ุงู‡ู… ุทูˆุงู„ ุดูˆ ุจูŠุนู…ู„ูˆุง ู‚ุงู„ูˆุง they increased
303
00:24:41,490 --> 00:24:45,030
vascular permeabilityุจูŠุฒูˆุฏูˆุง ุงู„ู„ูŠ ู‡ูˆ ุงู„
304
00:24:45,030 --> 00:24:50,390
permeability between ุงูŠุด within blood vessels ุทุจุนุง
305
00:24:50,390 --> 00:24:54,170
ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุงู„ vascular endothelial cells ุจูŠุฒูˆุฏ
306
00:24:54,170 --> 00:24:57,030
ุฃูŠุถุง ุงู„ expression of cell adhesion molecule ุนู„ู‰
307
00:24:57,030 --> 00:25:01,310
ุณุทุญู‡ุง ุฒูŠ ุงู„ E ูˆ ุงู„ P selected ูˆ ุงู„ ICAM 1 ุงู„ู„ูŠ ู‡ูˆ
308
00:25:01,310 --> 00:25:03,690
intracellular adhesion molecule number one
309
00:25:03,690 --> 00:25:08,340
ูˆุจุงู„ุชุงู„ูŠ ุจูŠุณู‡ู„ูˆุง ุงุฑุชุจุงุทุงู„ู€ Neutrophil ุจุงู„ู€
310
00:25:08,340 --> 00:25:11,980
endothelial cell ูˆู‡ุฐู‡ ุฃูˆู„ ุฎุทูˆุฉ ู…ู† ุฎุทูˆุงุช
311
00:25:11,980 --> 00:25:15,940
ุงู„ูุงุฌูˆุณุงูŠุชูˆุณุณ ุจุนุฏู‡ุง ุชุญุตู„ ููŠู‡ุง ุงู„ู€ Diabetes ูˆู‡ูŠ
312
00:25:15,940 --> 00:25:21,500
ุจุชู†ุทู„ู‚ ุงู„ู€ Neutrophil ุฅู„ู‰ ู…ูƒุงู† ุงู„ุญุฏุซ ุฌุงู…ุนุฉ ุงู„ู€
313
00:25:21,500 --> 00:25:29,920
Interferon ุจุชุฌุฐุจ ุชุนู…ู„ Calling ู„ู€ Macrophage ุจุชุฒุนุฌ
314
00:25:29,920 --> 00:25:35,020
ุนู„ูŠู‡ุง ููŠ ู…ู†ุทู‚ุฉ ุชูˆุงุฌุฏ ุงู„ู€ Antigentransforming
315
00:25:35,020 --> 00:25:38,840
growth factor beta ุจู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ ุฃูˆ ุจุณู…ูˆุท ูŠูˆู…ุฑ
316
00:25:38,840 --> 00:25:42,180
growth factor beta ุจู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ in terminating
317
00:25:42,180 --> 00:25:44,760
inflammatory response ู‡ูˆ ุนุจุงุฑุฉ ุนู† inhibitory
318
00:25:44,760 --> 00:25:52,920
cytokine ูˆุจุงู„ุชุงู„ูŠ ุจูŠุนู…ู„ ุงู„ู„ูŠ ู‡ูˆ accumulation
319
00:25:52,920 --> 00:25:57,200
and proliferation ู„ู„fibroblast ููŠ ู…ู†ุทู‚ุฉ ุงู„ุญุฏุซ and
320
00:25:57,200 --> 00:26:00,960
deposition of extracellular matrix protein ุงู„ู„ูŠ
321
00:26:00,960 --> 00:26:07,900
ู…ุทู„ูˆุจ for tissue repairุทุจ ุญุงุฌุฉ ุซุงู„ุซุฉ ุงู„ู„ูŠ ู‡ูˆ ุงู„
322
00:26:07,900 --> 00:26:11,680
chemokine ุฃูˆ ุงู„ cytokine that affect leukocyte
323
00:26:11,680 --> 00:26:17,160
movement ู‚ูˆู„ู†ุง they are usually low molecular
324
00:26:17,160 --> 00:26:21,800
weight chemotactic cytokine they have 70 to 80
325
00:26:21,800 --> 00:26:28,360
residue and they have conserved sequence and they
326
00:26:28,360 --> 00:26:33,590
are potent attractor ูŠุนู†ูŠุจูŠุฌุฒูˆุง ุจู‚ูˆุฉ for various
327
00:26:33,590 --> 00:26:36,590
leukocyte subsites ุทุจุนุง ุฃู‡ู…ู‡ุง ุงู„ู€ monocyte
328
00:26:36,590 --> 00:26:40,710
ู†ูŠูˆุชุฑูˆููŠู„ ุงู„ู€ monocyte ูˆ ุงู„ limphocyte example ุนู„ู‰
329
00:26:40,710 --> 00:26:48,350
ุงู„ chemokine includes IL-8 and this is produced by
330
00:26:48,350 --> 00:26:52,610
monocytes ูˆ mobilize
331
00:26:54,620 --> 00:27:01,120
ูˆ ูŠุฏูุน ุงู„ู†ูŠุชุฑูˆููŠู„ ูˆ ูŠุฏูุน ุงู„ุงู†ุฏุฑูˆุฌูŠู†ูŠุณูŠุณ ู‡ุฐุง ู‡ูˆ ุงู„ู€
332
00:27:01,120 --> 00:27:04,600
cytokine ุงู„ู…ู‡ู… ุฌุฏุง ุงู„ู„ูŠ ุจูŠุญูุธ ุงู„ู†ูŠุชุฑูˆููŠู„ ุนู„ู‰
333
00:27:04,600 --> 00:27:08,260
ุงุฑุชุจุงุท ุจุงู„ู…ูˆู„ูŠูƒูˆู„ ุงู„ุงู†ุชูŠุงุฌูŠุฉ ุงู„ู„ูŠ ุนู„ู‰ ุงู„ุณุทุญ ุงู„ู„ูŠ
334
00:27:08,260 --> 00:27:14,960
ุฅูŠู‡ุงุด ุงู„ blood vessels ุฑุงู†ุชุณ ุงู„ู„ูŠ ุงู†ุง ู‡ู†ุดูˆูู‡ ุดุบู„
335
00:27:14,960 --> 00:27:19,720
ุฑุงู†ุชุณ ู‡ูˆ ุนุจุงุฑุฉ ุนู† ุฃูŠุถุง cytokine produced by T
336
00:27:19,720 --> 00:27:26,860
lymphocytesูˆุจูŠุฎู„ู‘ูŠ ุงู„ู€Besophil ุชู€Degranulate
337
00:27:26,860 --> 00:27:34,160
ูˆุจูŠู†ุดู‘ุฑ ุชู„ูŠู†ูุณุงูŠุฒ ุงู„ู€ MCP-1 ุณู†ุดุงู‡ุฏู‡ ุงู„ุขู† ุฃูŠุถู‹ุง
338
00:27:34,160 --> 00:27:39,000
ุงุฎุชุตุงุฑุงุชู‡ุง ุฏูŠ Produced by monocyte and activate
339
00:27:39,000 --> 00:27:43,440
macrophage ุฃูŠุถู‹ุง Stimulate Besophil Histamine
340
00:27:43,440 --> 00:27:49,800
Release ูˆุจูŠุญูุธ ุฃูˆ ุจูŠุณุงุนุฏ ุนู„ู‰ ุชู†ุดูŠุท ุงู„ู€TL-B2
341
00:27:49,800 --> 00:27:59,190
pathwayุงู„ู€ MIP1 ูˆุจุฑู‡ู† ุงูˆ Alpha ู…ุตุงุฏุฑ ู…ู† ู…ูˆู†ูˆุณุงูŠุชุฒ
342
00:27:59,190 --> 00:28:06,330
ูˆู…ุดุงุฑูƒ ุชูŠุฑุจุฑ ูˆุงู† ูˆู„ูŠุณ ุชูŠุฑุจุฑ ุชูˆ ุงู…ูŠูˆู†ูŠุชูŠ ุงูŠุถุง ู‡ุฐุง
343
00:28:06,330 --> 00:28:09,870
MIP1
344
00:28:09,870 --> 00:28:13,990
ุจูŠุชุง ุงู„ู„ูŠ ุจูŠุทู„ุน ู…ู† ุงู„ู…ูˆู†ูˆุณุงูŠุชุฒ ูˆู†ูŠูˆุชุฑูˆููŠู„
345
00:28:13,990 --> 00:28:24,210
ูˆุงู†ุฏูˆุซูŠู„ูŠุง ุณูŠู„ ุจูŠู†ุงูุณ ู…ุน HIV 1for chemokine
346
00:28:24,210 --> 00:28:29,230
receptor binding ูŠุนู†ูŠ ุจู†ุงูุณ ุงู„ู€HIV ุฑูŠุณุจุชูˆุฑ ููŠ
347
00:28:29,230 --> 00:28:32,970
ุงู„ุฅุฑุชุจุงุท ู…ู† ุฑูŠุณุจุชูˆุฑู‡ ุชุจู‚ู‰ ุงุฎุชุตุงุฑุงุช ุงู„ู„ูŠ ุทูˆุจุฉ ู†ุฌุช
348
00:28:32,970 --> 00:28:36,450
ุนู„ูŠู†ุง MCP ุงู„ู„ูŠ ู‡ูˆ ุนุจุงุฑุฉ ุนู† monocyte chemotactic
349
00:28:36,450 --> 00:28:42,210
protein ูˆุงู„ู€MIB ู‡ูŠ ุนุจุงุฑุฉ ุนู† macro phage
350
00:28:42,210 --> 00:28:46,880
inflammatory proteinูˆุงู„ุฑุงู†ุชุณ ู‡ูˆ ุนุจุงุฑุฉ ุนู† regulated
351
00:28:46,880 --> 00:28:57,140
upon activation normalty expressed and secreted ุฏูŠ
352
00:28:57,140 --> 00:29:00,140
ุงู„ู„ูŠ ู‡ูˆ ุงู„ cytokines ุงู„ู„ูŠ ู‡ุช stimulate ู‡ู…ูˆุŒ
353
00:29:00,140 --> 00:29:05,600
hematopoiesis ุทุจุนุง ู‡ู… ุฃูƒุชุฑ ู‡ู… ุฃุฎุฏู†ุงู‡ู… ุงู„ cytokines
354
00:29:05,600 --> 00:29:10,880
ุฏูŠ ู‡ู… ู‚ุงุฏุฑูŠู† ุนู„ู‰ ุฅุณุชุฎุฏุงู… ุญุฑุงุฑุฉ ุญุฑุงุฑุฉ ุญุฑุงุฑุฉ ูˆ ุฃูŠุถุง
355
00:29:10,880 --> 00:29:17,720
they can be produced in vitroูˆ ุจูŠุณุชุฎุฏู…ูˆู‡ู… ููŠ
356
00:29:17,720 --> 00:29:22,200
culture media to induce hemopoiesis ูˆ ุจู†ุณู…ูŠู‡ู…
357
00:29:22,200 --> 00:29:25,800
collectively colon stimulating factor ุฃู…ุซู„ุฉ ูƒุซูŠุฑุฉ
358
00:29:25,800 --> 00:29:29,960
ุนู„ู‰ ุฐู„ูƒ ุฒูŠ ุงู„ macro phase colon stimulating factor
359
00:29:29,960 --> 00:29:34,700
ูˆ ุงู„ granulocyte colon stimulating factor GMCSF
360
00:29:34,700 --> 00:29:39,820
IL3 ูˆ ู‡ุฐุง ุจูŠุณู…ูˆู‡ ุฃุจูˆ ุงู„ cytokine stimulate clonal
361
00:29:39,820 --> 00:29:43,220
growth of large number of cell population ุนุดุงู† ุฃูŠู‡
362
00:29:43,220 --> 00:29:48,410
ุจูŠุณู…ูˆู‡ father of cytokinesุฃูŠุงู„ ุชู„ุงุชุฉ ููŠ ูˆุฌูˆุฏ
363
00:29:48,410 --> 00:29:56,770
ุงู„ุงุฑุชุฑูˆุจูŠุชูŠู† ุฃูŠุถู‹ุง ุจูŠุคุฏูŠ ุฅู„ู‰ ุชู†ุดูŠุท ุงูˆ ุงู„ุงุฑุชุฑูˆุจูŠุณูŠุณ
364
00:29:56,770 --> 00:30:03,510
ุจูŠุญูˆู„ ุงู„ู†ูˆุฑู…ูˆุจู„ุงุณ ู„ RBCs ูˆุฃูŠุงู„ ุณุจุนุฉ produced by
365
00:30:03,510 --> 00:30:08,230
bone marrow and thymic stromal cell ุจูŠุคุฏูŠ ุฅู„ู‰
366
00:30:08,230 --> 00:30:12,160
differentiation of lymphoid stem cellู„ู€ B
367
00:30:12,160 --> 00:30:20,060
-Lymphocyte ูˆT-Lymphocyte ุงู„ู€ GCSF ุฃูŠุถู‹ุง ุจูŠุณุชุฎุฏู…
368
00:30:20,060 --> 00:30:24,040
to reverse ู†ูŠูˆุชุฑูˆุจูŠู†ูŠุง ูŠุนู†ูŠ ูˆุงุญุฏ ุนู†ุฏู‡ ู†ูŠูˆุชุฑูˆุจูŠู†ูŠุง
369
00:30:24,040 --> 00:30:27,740
ุจูŠุฒูˆุฏ ุชู†ุดูŠุท ุฃูˆ ุชูƒูˆูŠู† ุงู„ู†ูŠูˆุชุฑูˆููŠู„
370
00:30:32,590 --> 00:30:36,270
ุจู†ุฒูˆุฏ ุนุฏุฏ ุงู„ู€ Neutrophil ูˆู‡ุฐุง ุจูŠุณุชุฎุฏู… ููŠ ุญุงู„ุงุช ุงู„ู€
371
00:30:36,270 --> 00:30:41,430
high-dose chemotherapy ุงู„ู€ GMCSF ุฃูŠุถู‹ุง is used to
372
00:30:41,430 --> 00:30:43,490
treat patients undergoing bone marrow
373
00:30:43,490 --> 00:30:48,390
transplantation ุดูˆ ูˆุธูŠูุชู‡ ุจูŠุนู…ู„ boosting for
374
00:30:48,390 --> 00:30:53,220
clonal expansion of granulocyte and macrophageูˆ
375
00:30:53,220 --> 00:31:00,480
ู‡ุฐู‡ ุฃู…ุซู„ุฉ ูƒุซูŠุฑุฉ ุนู„ู‰ ุงู„ู€ hemopoietic cytokine ุทุจ
376
00:31:00,480 --> 00:31:04,100
ู†ูŠุฌูŠ ู†ุญูƒูŠ ุนู„ู‰ ุงู„ cytokine receptor ู‚ุงู„ูˆุง these
377
00:31:04,100 --> 00:31:09,040
cytokine can act collectively ุฃู†ุง ุจุญูƒูŠู‡ุง ู„ุบุงูŠุฉ
378
00:31:09,040 --> 00:31:12,820
cytokine collectively can act only on target cells
379
00:31:14,360 --> 00:31:17,480
ุงู„ู„ูŠ ุนู„ู‰ ุณุทุญู‡ุง receptor for the cytokine ู…ุง
380
00:31:17,480 --> 00:31:20,780
ุจูŠุดุชุบู„ูˆุง ุนู„ู‰ ูƒู„ ุงู„ุฎู„ุงูŠุง ูู‚ุท ุงู„ุฎู„ุงูŠุง ุงู„ู„ูŠ ุนู„ู‰ ุณุทุญู‡ุง
381
00:31:20,780 --> 00:31:25,060
receptor for the cytokine ุดูˆ ุจูŠุนู…ู„ูˆู‡ ุงู„ resting
382
00:31:25,060 --> 00:31:31,500
cell ููŠ ุงู„ุบุงู„ุจ do not express receptor ู…ุงุดูŠ or
383
00:31:31,500 --> 00:31:36,350
they express it in low affinityุงู„ุนุงู…ู„ ุนู„ู‰ ุฐู„ูƒ IL-2
384
00:31:36,350 --> 00:31:40,770
ุฑูŠุณูŠุจุชูˆุฑ ู‡ูˆ ุงู„ู€ Intermediate Affinity Diameter
385
00:31:40,770 --> 00:31:47,470
ุจูŠุชุงุฌุงู…ุน ุงู„ู€ Chain ุฃูˆ ูŠู…ูƒู† ุฃู† ูŠูƒูˆู† ู…ูˆุตูˆู„ุง ููŠ High
386
00:31:47,470 --> 00:31:51,330
Affinity Diameter ูŠูˆู… ูŠูƒูˆู† ุนุงู…ู„ ุงู„ู€ Chain ุจูŠูƒูˆู†
387
00:31:51,330 --> 00:31:54,230
Low Affinityุจู‚ู‰ ุฏูŠ ููŠ ุงู„ resting cell ู„ูƒู† ูŠูˆู… ู…ุง
388
00:31:54,230 --> 00:31:59,410
ุชุชู†ุดู‚ ุจุชุชุญูˆู„ ุฅู„ู‰ ุงู„ู„ูŠ ู‡ูˆ triangular ูŠุนู†ูŠ three
389
00:31:59,410 --> 00:32:03,030
chain
390
00:32:03,030 --> 00:32:09,350
receptors ุงู„ู„ูŠ ู‡ู… Alpha, Beta, Gamma ูˆุจุงู„ุชุงู„ูŠ in
391
00:32:09,350 --> 00:32:14,350
response to IL-2 secretion ุทุจุนุง ุงู„ู…ุนู„ูˆู…ุงุช ุงู„ู„ูŠ
392
00:32:14,350 --> 00:32:17,950
ุงุณุชู‚ู„ุช ู…ู† ุงู„ cytokine to cytokine receptor
393
00:32:17,950 --> 00:32:28,260
interactionุจุฏุช ุฅู„ู‰ ุงู„ู‰
394
00:32:28,260 --> 00:32:36,760
ูˆุถุน ุฎุทุท ู„ู…ู†ุน ูˆุธุงุฆู ุงู„ู€ cytokine ุฃุซู†ุงุก ุงู„ู€
395
00:32:36,760 --> 00:32:40,420
inflammatory responsesุฒูŠ ููŠ ุญุงู„ุงุช Rheumatoid
396
00:32:40,420 --> 00:32:44,220
Arthritis ุงูˆ Transplantation Rejection ูŠุนู†ูŠ ุงู„ูŠูˆู…
397
00:32:44,220 --> 00:32:47,260
ู…ุนุฑูุชู†ุง ู…ู† ุฎู„ุงู„ ู…ุนุฑูุชู†ุง ู„ู„ู€ cytokine to cytokine
398
00:32:47,260 --> 00:32:53,880
receptor interaction ุงู‚ุฏุฑู†ุง ู†ุณุชุฎู„ุต ุงุณุชุฑุงุชูŠุฌูŠุงุช
399
00:32:53,880 --> 00:33:00,420
ุนู„ุงุฌูŠุฉ ู„ู…ู†ุน ูˆุธุงุฆู ุงูˆ ุนู…ู„ ุจุนุถ ุงู„ cytokine ุงุซู†ุงุก
400
00:33:00,420 --> 00:33:03,620
ุญุงู„ุงุช ู…ุฑุถูŠุฉ ุฒูŠ Rheumatoid Arthritis ุงูˆ
401
00:33:03,620 --> 00:33:11,380
Transplantation ุทูŠุจ ู‚ุณู…ูˆุง ุงู„ receptorsุฃูˆ ุฎู…ุณ
402
00:33:11,380 --> 00:33:17,780
ุนุงุฆู„ุงุช ูƒุจูŠุฑุฉ ุงู…ุง immunoglobulin superfamily
403
00:33:17,780 --> 00:33:24,540
receptor ุงูˆ class one cytokine receptorุฃูˆ ุจูŠุณู…ูˆู‡ู…
404
00:33:24,540 --> 00:33:28,420
hemopoietin receptor family ูˆ class 2 cytokine
405
00:33:28,420 --> 00:33:32,920
receptor ุฃูˆ ุจูŠุณู…ูˆู‡ู… interferon receptor family ุซู…
406
00:33:32,920 --> 00:33:36,140
transform ุฃูˆ tumor necrosis factor receptor super
407
00:33:36,140 --> 00:33:42,060
family and chemokine receptor family ุฎู…ุณ ุนุงุฆู„ุงุช
408
00:33:42,060 --> 00:33:46,080
ูˆู‡ุฐุง ู‡ู… ููŠ ุงู„ุตูˆุฑุฉ ุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู† ู‡ูŠ ุงู„
409
00:33:46,080 --> 00:33:50,560
immunoglobulin super familyูˆู‡ูŠ ุฃู…ุซู„ุฉ ุนู„ู‰ cytokine
410
00:33:50,560 --> 00:33:57,860
ุชุฑุชุจุท ููŠู‡ุง ุซู… class one cytokine receptor ูˆู‡ูŠ ูƒู…ุงู†
411
00:33:57,860 --> 00:34:03,320
ุฃู…ุซู„ุฉ ุนู„ู‰ ุฐู„ูƒ ุซู… class two ุซู… human cross factor
412
00:34:03,320 --> 00:34:08,160
ุซู… chemokine receptor ุฃู…ุซู„ุฉ ุทุจุนุง ุฒูŠ ู…ุง ุงู†ุชูˆุง
413
00:34:08,160 --> 00:34:13,320
ุดุงูŠููŠู† receptor ู„ู‡ุง ุฃุดูƒุงู„ ู…ุฎุชู„ูุฉ ู„ูƒู† ูƒู„ู‡ุง ุชุดุชุฑูƒ ููŠ
414
00:34:13,320 --> 00:34:16,660
different domains ุฒูŠ ู…ุง ู‡ู†ุดูˆู ุงู„ุขู†
415
00:34:19,980 --> 00:34:20,880
ุงู„ุนุงุฆู„ุฉ ุงู„ุฃูˆู„ุงู†ูŠุฉ ุงู„ู„ูŠ ุจูŠุฌูŠ ุจุชุงุนุฉ ุงู„
416
00:34:20,880 --> 00:34:24,480
Immunoglobulin Superfamily Receptor ู„ุฏูŠู‡ุง ุนู„ู‰
417
00:34:24,480 --> 00:34:25,860
ุงู„ุฃู‚ู„ ูˆุงุญุฏุฉ ู…ู† ุงู„ู…ุณุชูˆู‰ ุงู„ู…ุดุงุจู‡ ู„ู„ุฅู…ูŠู†oglobulin
418
00:34:25,860 --> 00:34:31,080
ูŠุนู†ูŠ ุฒูŠ ู…ุง ู‚ู„ู†ุง ููŠู‡ domain ู…ูˆุฌูˆุฏุฉ ููŠู‡ุง ุฏูŠ Receptor
419
00:34:31,080 --> 00:34:34,000
ูุงู„ุนุงุฆู„ุฉ ุงู„ุฃูˆู„ุงู†ูŠุฉ ุงู„ู„ูŠ ุจูŠุฌูŠ ุจุชุงุนุฉ ุงู„
420
00:34:34,000 --> 00:34:38,400
Immunoglobulin Superfamily Receptor ูˆู‚ุช ุชุถู… ุนุงุฆู„ุฉ
421
00:34:38,400 --> 00:34:46,840
ุทูˆูŠู„ุฉ ู…ู† ุงู„ Receptor ุจูŠุญุชูˆูŠ Receptor ุชุจุนู‡ุง at
422
00:34:46,840 --> 00:34:53,480
least for one immunoglobulinLike Domain Class I
423
00:34:53,480 --> 00:34:57,900
ุณูŠุทูˆูƒุงูŠู† ุฑูŠุณุจุชูˆุฑ ุฃูˆ ุณู…ูˆู‡ุง hemopoietin receptor
424
00:34:57,900 --> 00:35:06,440
family ุจุชุชูƒูˆู† ู…ู† two polypeptide chain ูˆ ูˆุงุญุฏุฉ
425
00:35:06,440 --> 00:35:11,380
alphaู…ุดู‡ูˆุฑุฉ ุนู† ุงู„ signal transduction ูˆุงุญุฏุฉ Alpha
426
00:35:11,380 --> 00:35:14,400
ูˆุงู„ุชุงู†ูŠุฉ Beta ุงู„ู„ูŠ ู‡ูŠ ู…ุณู‡ูˆู„ุฉ ุนู† ุงู„ signal
427
00:35:14,400 --> 00:35:18,820
transduction ูˆู…ู…ูƒู† ุชูƒูˆู† ุงู…ุง Beta ูˆุงู…ุง Gamma ุญุณุจ
428
00:35:18,820 --> 00:35:23,680
ู†ูˆุน ุงู„ู„ูŠ ู‡ูˆ ุงู„ cytokine ู…ุนุธู… ุงู„ cytokine ุจุชุณุชุฎุฏู…
429
00:35:23,680 --> 00:35:28,660
ุงู„ู„ูŠ ู‡ูˆ class one family
430
00:35:28,660 --> 00:35:36,260
class one receptor family ุงู…ุซู„ ุนู„ูŠู‡ุง ู‡ูŠ ุฒูŠ ุงู„ I L2
431
00:35:36,260 --> 00:35:46,190
I L3 I L5Y15 ูˆ GM ูˆ GCSF Class 2 ุงูˆ ุจูŠุณู…ูˆู‡ุง ุงู„
432
00:35:46,190 --> 00:35:52,730
Interferon ู…ุงุดูŠ Receptor family ุงู„ู„ูŠ
433
00:35:52,730 --> 00:35:58,050
ูƒุงู†ุช ุชุจุนู‡ุง ู‡ูˆ ุงู„ Interferon and they have
434
00:35:58,050 --> 00:36:06,320
biological activity that overlapู…ุน ุงู„ุฐูŠู† ู…ุฑุชุจุทูŠู†
435
00:36:06,320 --> 00:36:12,960
ุจู€ Interferon ุฒูŠ IL-10.Tumor Necrosis Factor
436
00:36:12,960 --> 00:36:20,480
Receptor Superfamily ู…ุฏูŠู†ุฉ ู…ู† ุฎู„ุงู„
437
00:36:20,480 --> 00:36:24,580
ู…ุฌู…ูˆุนุฉ ู…ู† ุงู„ู€ Adapter Protein ุจูŠุณู…ูˆู‡ุง ุงู„ู€Tumor
438
00:36:24,580 --> 00:36:30,600
Necrosis Factor Receptor Associated Factor ูˆ ู‡ุฐู‡
439
00:36:30,600 --> 00:36:35,600
ุงู„ู€ Receptorูˆุงู„ู†ูƒุฑูˆุณูŠุณ ูุงูƒุชูˆุฑูŠุง ุงู„ุงู†ุชุดุงุฑูŠุฉ
440
00:36:35,600 --> 00:36:36,180
ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ
441
00:36:36,180 --> 00:36:38,240
ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ
442
00:36:38,240 --> 00:36:39,620
ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ
443
00:36:39,620 --> 00:36:43,440
ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ
444
00:36:43,440 --> 00:36:48,460
ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ
445
00:36:48,460 --> 00:36:48,920
ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ
446
00:36:48,920 --> 00:36:51,020
ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ
447
00:36:51,020 --> 00:36:52,740
ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ
448
00:36:52,740 --> 00:37:00,540
ุงู„ุงู†ุชุดุงุฑูŠุฉ ุงู„ุงู†ุชุดุงุฑูŠุฉ
449
00:37:01,880 --> 00:37:25,120
ูˆู‡ูŠ ู…ูˆุฌูˆุฏุฉ ููŠ ู…ุฌู…ูˆุนุฉ
450
00:37:25,120 --> 00:37:28,620
ู…ุชุจุงูŠู†ุฉ ู…ู† ุงู„ู€ pathogen ู…ุซู„
451
00:37:31,150 --> 00:37:35,750
Stryptococcus pneumonia ุงู„ู„ูŠ ุจุชุฑุชุจุท ุจุงู„ู€ Platelet
452
00:37:35,750 --> 00:37:40,270
Activating Factor Receptor ุจุชุฑุชุจุท ุจุงู„ู€ Plasmodium
453
00:37:40,270 --> 00:37:47,110
V-Vax ุงู„ู„ูŠ ุจุฑุชุจุท ุจุงู„ู€ Duffy Blood Group Antigen
454
00:37:47,110 --> 00:37:54,410
ุจุชุฑุชุจุท ุจุงู„ู€ HIV-1 ุงู„ู„ูŠ ุงู„ู€ Receptor ุชุจุนู‡ ุนุจุงุฑุฉ ุนู†
455
00:37:54,410 --> 00:37:59,310
CXC R4 ูˆ Chemokine Receptor 5
456
00:38:01,950 --> 00:38:05,790
ู‡ุคู„ุงุก ุงู„ู…ุณุคูˆู„ูŠู† ู„ู€ Viral Entry into T Cell and
457
00:38:05,790 --> 00:38:10,950
Macrophage Respectively ูˆู‡ุฐุง
458
00:38:10,950 --> 00:38:18,050
ุนุจุงุฑุฉ ุนู† ุฏูˆุฑ ุงู„ู€ cytokine in disease ุฑุงุญุธูˆุง ุงู„ุฎูุฌุฑ
459
00:38:18,050 --> 00:38:25,490
ูƒูŠู ุชุตุจุญ ุงู„ู‚ุงู„ูŠุฉ ุทุจุนุง ู‡ุฐุง ุนุจุงุฑุฉ ุนู† Receptor ู…ุฑุชุจุท
460
00:38:25,490 --> 00:38:28,690
ุจู€ Adapter ุจุฑูˆุชูŠู†ุงูŠ ููŠ ุงู„ุฏุงุฎู„ ู…ู† ุฏุงุฎู„ ุงู„ู€
461
00:38:28,690 --> 00:38:30,730
Intracytoplasmic
462
00:38:32,560 --> 00:38:37,500
ุจูˆุฑุดูŠู† ู…ุฑุชุจุท ุจุงู„ ุฌุงูƒูŠ ุจุฑูˆุชูŠู† ุฃูŠ ุงู„ cytokine ูŠูุฑุฒ
463
00:38:37,500 --> 00:38:44,680
ูŠุฑูˆุญ ูˆ ู…ุฑุชุจุท ุจ ุงู„ receptor ุชุจุนู‡ ูู…ุชู…ุง ุงุฑุชุจุท ุจุงู„
464
00:38:44,680 --> 00:38:48,040
receptor ุชุจุนู‡ ุจูŠุตูŠุฑ ููŠู‡ ุงู„ diamerization ุดุงูŠููŠู†
465
00:38:48,040 --> 00:38:53,400
ูƒุฏู‡ ู…ุชุจุงุนุฏ ุงู„ receptor ุนู† ุจุนุถ ู„ูƒู† ูŠูˆู… ูŠุฌูŠ ุงู„
466
00:38:53,400 --> 00:38:57,040
cytokine ูŠูุฑุฒ ุจูŠุนู…ู„ diamerization ู„ ุงู„ receptors
467
00:38:57,040 --> 00:39:00,630
ู…ุชู…ุง ุตุงุฑ ููŠ diamerization ูˆ ูŠุฑุดูƒู„ู‡ ูŠุนู†ูŠุจุตูŠุฑ
468
00:39:00,630 --> 00:39:03,170
activation ู„ู„ุฌุงูƒ ุงู„ู„ูŠ ู‡ูˆ ุงู„ adaptor ุงู„ุจุฑูˆุชูŠู†
469
00:39:03,170 --> 00:39:08,230
ุงู„ุฏุงุฎู„ูŠ ู…ุงุดูŠ ูˆ ู‡ุฐู‡ ุนุจุงุฑุฉ ุนู† energy dependent
470
00:39:08,230 --> 00:39:14,430
process ู†ูู‚ุฏ ููŠู‡ุง ุทุงู‚ุฉ ATP ุจูŠุชุญูˆู„ ู„ ADP ูˆ ููŠ ู†ูุณ
471
00:39:14,430 --> 00:39:20,870
ุงู„ูˆู‚ุช ุจูŠุตูŠุฑ phosphorylation ู„ู„ ุงู„ู„ูŠ ู‡ูˆ ุงู„ุฌุงูƒ ูŠุนู†ูŠ
472
00:39:20,870 --> 00:39:25,750
ุจุงู„ุทุจุท ูˆ ุนู†ุฏู…ุง ุตุงุฑ ููŠ activation ู„ู„ุฌุงูƒ ุจู†ุดุทู„ู†ุง
473
00:39:25,750 --> 00:39:32,770
another ุงู„ู„ูŠ ู‡ูˆ ุงู„ุจุฑูˆุชูŠู†ุจุณู…ูˆู‡ STAT ุจูŠุนู…ู„ูˆุง
474
00:39:32,770 --> 00:39:36,030
phosphorylation ู…ุงุช ุจุฑุถู‡ ู…ุงุชุตุฑููˆุง ุงู„
475
00:39:36,030 --> 00:39:38,990
phosphorylation ู„ู„ STAT ุจูŠุฑูˆุญูˆุง ูˆุตุงุฑู„ู‡
476
00:39:38,990 --> 00:39:46,050
Diamerization ูˆุฅุฐุง ุงุชุญุตุฑ Diamerized ุงู„ STAT ุจูŠู†ุชู‚ู„
477
00:39:46,050 --> 00:39:52,510
ุงู„ู‰ ุงู„ nucleus ูˆ ู‡ู†ุงูƒ ุจุฑุชุจุท ุจุฌูŠู†ุงุช ุงู„ู…ุณุฆูˆู„ุฉ ุนู†
478
00:39:52,510 --> 00:39:59,690
transcription of specific air ุงู„ู„ูŠ ู‡ูˆ action
479
00:40:01,290 --> 00:40:06,410
ู…ุดูŠ ุจูŠุฏู‡ุง ุนู„ู‰ ุงู„ุณุฑูŠุน ููŠ ุงู„ูˆุถุน ุงู„ุทุจูŠุนูŠ ุงู„ู€ Receptor
480
00:40:06,410 --> 00:40:11,010
ู…ุชุจุงุนุฏ ู…ุฑุชุจุท ุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู† ุฃูŠู‡ ุจูŠุชูƒูˆูŠู† ู…ู†
481
00:40:11,010 --> 00:40:15,210
Extra Cellular ูˆ Transmembrane ูˆ Intracytoplasmic
482
00:40:15,210 --> 00:40:19,390
portion ุงู„ Intracytoplasmic portion ู…ุฑุชุจุท
483
00:40:19,390 --> 00:40:24,370
ุจุจุฑูˆุชูŠู†ุงุช ุจูŠุณู…ูˆู‡ุง Adapter Protein ุงู„ู„ูŠ ู‡ูˆ ุงู„ Jack
484
00:40:24,370 --> 00:40:30,470
ุงู„ู„ูŠ ู‡ูˆ ุนุจุงุฑุฉ ุนู† Genus Activated Kinase ู…ุดูŠ
485
00:40:31,850 --> 00:40:35,350
This ุฏู‡ ู‡ูˆ ุจู…ุฌุฑุฏ ู…ุง ูŠูุฑุฒ ุงู„ู€ cytokine
486
00:40:35,350 --> 00:40:41,110
Automatically ุงู„ุฑูŠุณูŠุจุชุฑ ุจูŠุณู…ู„ู‡ Diamerization ุจูŠุฌุฑุจ
487
00:40:41,110 --> 00:40:45,370
ู…ู† ุจุนุถู‡ ูˆู…ุชู…ุง ุฌุฑุจ ู…ู† ุจุนุถู‡ ุฏู‡ ู‡ูˆ ุตุงุฑู„ู‡
488
00:40:45,370 --> 00:40:49,130
Diamerization ูŠุนู†ูŠ ุบูŠุฑ ุดูƒู„ู‡ ูุฏูŠ ุฑุณุงู„ุฉ ู„ู„ jack ุงู„
489
00:40:49,130 --> 00:40:53,650
routine to be activated ูุฏู‡ ู‡ูˆ ุจุชู†ุทู‚ ุทุจุนุง ู‡ุฐู‡
490
00:40:53,650 --> 00:40:57,670
energy independent ุฒูŠ ู…ุง ุดูู†ุง ุงู„ ATP ุจูŠูู‚ุฏ ูˆู…ุชุญูˆู„
491
00:40:57,670 --> 00:41:02,560
ู„ ADP ู‡ุชู†ุดุท ุงู„ jackุงู„ู„ูŠ ุจู†ุดุทู„ู†ุง ุนู„ู‰ ุงู„
492
00:41:02,560 --> 00:41:05,060
transcriptional factor ุงู„ู„ูŠ ู‡ูˆ ุนุจุงุฑุฉ ุนู† ุงู„ุณุชุงุช
493
00:41:05,060 --> 00:41:11,440
ุงู„ุจุฑูˆุชูŠู† ูˆ ู„ู…ุง ุงุชู†ุดุท ุงู„ุณุชุงุช ุจุณ ุงู„ modernization
494
00:41:11,440 --> 00:41:16,940
ุงู„ู„ูŠ ุจูŠุชุณู‡ู„ ุฏุฎูˆู„ู‡ ู„ ุงู„ nucleus ูˆ ู‡ู†ุงูƒ ูŠุฑูˆุญ ุนู„ู‰ ุงู„
495
00:41:16,940 --> 00:41:21,600
DNA ูˆูŠุฑุชุจุท ุจุฌูŠู†ุงุช ู…ุนูŠู†ุฉ ุจูŠุญูุธ ุนู„ู‰ ุงู„ transcription
496
00:41:21,600 --> 00:41:27,680
ุชุจุนุชู‡ุง ูุฑุตุฉ ุงู‡ ูˆุจุงู„ุชุงู„ูŠ ุจูŠูƒูˆู† ุจุฑูˆุชูŠู† which induce
497
00:41:27,680 --> 00:41:28,320
activity
498
00:41:34,750 --> 00:41:39,810
Cytokine must generate intracellular signal ุทุจุนุง
499
00:41:39,810 --> 00:41:45,390
ู‡ุฐุง ูŠุคุฏูŠ ุฅู„ู‰ ุงู†ุชุฌุฑ ุงู„ู€ active transcriptional
500
00:41:45,390 --> 00:41:49,230
factor ูˆุจุงู„ุชุงู„ูŠ ููŠ ู†ู‡ุงูŠุฉ ุจูŠุตูŠุฑ ููŠู‡ gene expression
501
00:41:49,230 --> 00:41:53,710
ุฒูŠ ู…ุง ุฃุดูˆู ู…ุทูˆู„ุฉ ู‡ุฐุง ุนุจุงุฑุฉ ุนู† ุดุฑุญ ู„ู‡ุฐุง ุงู„ู…ูˆุถูˆุน
502
00:41:53,710 --> 00:41:56,870
ุงู„ู„ูŠ ู‚ุจู„ ุฃู† ุฃุชูƒู„ู… ุนู†ู‡ binding of a cytokine to its
503
00:41:56,870 --> 00:42:01,270
cellular receptor ู…ุงุฐุง ุจูŠุนู…ู„ุŸ ุจูŠุนู…ู„ polymerization
504
00:42:01,270 --> 00:42:02,130
ุฃูˆ
505
00:42:05,690 --> 00:42:09,850
Signaling is initiated by activation of JAK, ู†ุดุท
506
00:42:09,850 --> 00:42:14,530
JAK kinases.ู‡ุฐุง ุนุจุงุฑุฉ ุนู† family of cytosolic
507
00:42:14,530 --> 00:42:20,030
protein tyrosine kinase ุจูŠุตูŠุฑ ููŠ interaction that
508
00:42:20,030 --> 00:42:27,100
interact with cytoplasmic domainุทุจุนุง ู‡ุฐุง ุจูŠุคุฏูŠ ุงู„ู‰
509
00:42:27,100 --> 00:42:30,760
phosphorylation of tyrosine residue ุงู„ู„ู‰ ู…ูˆุฌูˆุฏุฉ ููŠ
510
00:42:30,760 --> 00:42:34,400
ุงู„ู€cytoplasmic ุฏูˆูŠู† of the receptor ุงู† ุดุฑุญุชู‡ ู‡ุฐุง
511
00:42:34,400 --> 00:42:38,320
ุงู„ูƒู„ุงู… ุทูˆุฃ ุดุฑุญุชู‡ ุนู„ู‰ ุงู„ูุฌุฑ ุฃู†ุง and on a family of
512
00:42:38,320 --> 00:42:41,460
transcriptional factors ุจูŠุณู…ูˆู‡ุง STAT ุงูˆ ุจุงู‚ุชุตุงุฑู‡ุง
513
00:42:41,460 --> 00:42:46,820
ู„ signal transduction and activator of
514
00:42:46,820 --> 00:42:47,640
transcription
515
00:42:51,360 --> 00:42:55,400
ุจุงู„ุทุจุน ู…ุฑุฉ ูƒุงู†ุช ููˆุณููˆุฑูŠู„ูŠุฉ ู…ู† ู…ุตุงุฏุฑ ุงู„ุชุดุฑูŠูƒุงุช
516
00:42:55,400 --> 00:42:56,020
ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช
517
00:42:56,020 --> 00:42:57,380
ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช
518
00:42:57,380 --> 00:42:59,620
ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช
519
00:42:59,620 --> 00:42:59,920
ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช
520
00:42:59,920 --> 00:43:01,940
ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช
521
00:43:01,940 --> 00:43:02,180
ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช
522
00:43:02,180 --> 00:43:12,640
ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒุงุช ุงู„ุชุดุฑูŠูƒ
523
00:43:14,550 --> 00:43:19,130
ุจุชูƒูˆู† ู…ุตุญูˆุจุฉ ุจู€ cytoplasmic protein ุจูŠุณู…ูˆู‡ู… ุจุฅูุฑุงุฒ
524
00:43:19,130 --> 00:43:22,870
ุทุจุนุง ุชูƒูˆูŠู† cytoplasmic protein ุจูŠุณู…ูˆู‡ู… suppressor
525
00:43:22,870 --> 00:43:28,590
of cytokine suppressor of cytokine ุฃูˆ ุจูŠุณู…ูˆู‡ู… SOX
526
00:43:28,590 --> 00:43:34,290
protein and this signaling protein regulate the
527
00:43:34,290 --> 00:43:38,590
signal transduction ู…ู† ุฎู„ุงู„ ุงุฑุชุจุงุท ุจู€ cytokine
528
00:43:38,590 --> 00:43:41,590
receptor ูˆุจุงู„ุชุงู„ูŠ ุงู„ signaling protein
529
00:43:45,750 --> 00:43:51,090
ุจุตูŠุฑ ู„ู‡ุง ุฏูŠ degradation ูŠุนู†ูŠ .. ูŠุนู†ูŠ ู…ุชู‰ ู…ุง ู‡ูŠ
530
00:43:51,090 --> 00:43:56,130
ุจุชู†ุงูุณ ุงู„ .. ุงู„ู„ูŠ ู‡ูˆ ุงู„ signaling ุจุฑูˆุชูŠู† ููŠ
531
00:43:56,130 --> 00:44:00,190
ุงู„ุงุฑุชุจุงุท ุจุงู„ receptor ุชุจุนุชู‡ ูˆุจุงู„ุชุงู„ูŠ ุจูŠุจุทู„ ููŠ
532
00:44:00,190 --> 00:44:05,030
action ู„ู…ูŠู† ููŠ ุชูƒูˆูŠู† ุงู„ cytokine ุงูˆ ูˆุจุงู„ุชุงู„ูŠ ู…ุงููŠุด
533
00:44:05,030 --> 00:44:09,970
reaction ุฏูŠ regulation of normal socks ุจู„ุนุจ ุฏูˆุฑ
534
00:44:09,970 --> 00:44:21,070
ูƒุจูŠุฑููŠ ุญุงู„ุงุช ู…ุฑุถูŠุฉ ู…ุฎุชู„ูุฉ ุงู„ู„ู‚ุจ ููŠ ู‡ุฐู‡ ุงู„ุทุจุงู„
535
00:44:21,070 --> 00:44:28,050
ู†ุงุญูŠุฉ ุนู„ุงุฌูŠุฉ ุทุจุนุง ุงุณุชุฎุฏุงู… ุงู„ protein can
536
00:44:28,050 --> 00:44:35,090
manipulate the function of certain cytokine
537
00:44:35,090 --> 00:44:40,270
ูˆุจุงู„ุชุงู„ูŠ we can treat diseases by using them
538
00:44:43,160 --> 00:44:47,440
ุทุจ ู†ุดูˆู ุฏูˆุฑู‡ู… ุฏูˆุฑ ุงู„ cytokine ููŠ ุญุงู„ุงุช ู…ุฑุถูŠุฉ ู†ู…ุฑ
539
00:44:47,440 --> 00:44:54,200
ูˆุงุญุฏ toxic shock syndrome ุบุงู„ุจุง ุจู†ุดูˆูู‡ุง ู„ู…ุง ู‚ู„ู†ุง
540
00:44:54,200 --> 00:44:58,200
ู„ู…ุง ุจูŠุฎุด ุงู„ antigen ุจูƒู…ูŠุฉ ูƒุจูŠุฑุฉ ุจูŠุชูˆูุฑุฒ ุงู„
541
00:44:58,200 --> 00:45:00,880
cytokine ุจูƒู…ูŠุฉ ูƒุจูŠุฑุฉ ูˆ ุจุชุนู…ู„ู†ุง toxic shock
542
00:45:00,880 --> 00:45:04,080
syndrome ุดูˆ ุงู„ู„ูŠ ุจูŠุตูŠุฑ it's initiated by the
543
00:45:04,080 --> 00:45:07,020
release of super antigen ููŠ ุญุงู„ุฉ ุงู„ super antigen
544
00:45:08,870 --> 00:45:11,170
ุดูˆ ุงู„ู„ูŠ ุจูŠุตูŠุฑุŸ ุจุชูƒูˆู† ูƒู…ูŠุฉ ูƒุจูŠุฑุฉ ู…ู† ุงู„ู€ cytokine
545
00:45:11,170 --> 00:45:17,310
ุงู„ู„ูŠ ุจุชู†ุดุฑ ูƒู…ูŠุฉ ูƒุจูŠุฑุฉ ู…ู† ุงู„ู€ T lymphocyte ู‡ูˆ ูŠุนู†ูŠ
546
00:45:17,310 --> 00:45:20,490
ุจูŠู‚ูˆู„ูˆุง ุงู† ู‡ูˆ ุงู„ูุฑู‚ ุจูŠู† ุงู„ antigen ุงู„ุนุงุฏูŠ ูˆุงู„
547
00:45:20,490 --> 00:45:22,690
super antigen ุฏุฎูˆู„ ุงู„ antigen ุงู„ุนุงุฏูŠ ูˆุงู„ super
548
00:45:22,690 --> 00:45:27,810
antigen ููŠ ุชู†ุดูŠุท ุงู„ T lymphocyte ุชู‚ุฑูŠุจุง ููŠ ูˆุฌูˆุฏ ุงู„
549
00:45:27,810 --> 00:45:34,490
antigen ุงู„ุนุงุฏูŠ ูˆุงุญุฏ ู…ู† ุนุดุฑ ุชู„ุงู ู…ู† ุงู„ T lymphocyte
550
00:45:34,490 --> 00:45:40,820
ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ ููŠ ุงู„ุฌุณู… ุชุชู†ุดุฑุจูŠู†ู…ุง ููŠ ูˆุฌูˆุฏ ุงู„ super
551
00:45:40,820 --> 00:45:44,760
antigen ูƒู„ ุงู„ cytokine ุงู„ุชู„ูŠููˆุณูŠุช ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ ููŠ
552
00:45:44,760 --> 00:45:50,700
ุงู„ุฌุณู… ุชุชู†ุดุฑ ูุชุฎูŠู„ ุงู„ูุฑู‚ ุจูŠู† ุงู„ุชุงู†ูŠู† ุทุจุนุง ู‡ุฐุง ุจูŠุฃุฏูŠ
553
00:45:50,700 --> 00:45:55,980
ุฅู„ู‰ ู‡ุฐุง ุจูŠ .. ุจูŠ .. ุจูŠ .. ุจูŠ .. ุจูŠุตูŠุฑ ููŠ ูˆุฌูˆุฏ
554
00:45:55,980 --> 00:45:59,480
excessive
555
00:45:59,480 --> 00:46:04,200
production of cytokine ูˆูˆุฌูˆุฏ ู„ู„ cytokine ุจูƒู…ูŠุฉ
556
00:46:04,200 --> 00:46:09,980
ูƒุจูŠุฑุฉ ุจุชุนู…ู„ dysregulation ู„ู„Cytokine Network ุจูŠุคุฏูŠ
557
00:46:09,980 --> 00:46:14,680
ุงู„ู‰ I level YL1 and tumor necrosis factor ูˆ ู‡ุฏูˆู„ุฉ
558
00:46:14,680 --> 00:46:17,760
ุงู„ cytokine two cytokine ุฏูŠ induce systemic
559
00:46:17,760 --> 00:46:24,000
reaction ุจู…ุง ููŠู‡ุง ุงู„ููŠูˆุฑ ูˆ blood clotting ุฏูŠุงุฑูŠุฉ
560
00:46:24,000 --> 00:46:28,080
drop in blood pressure and shock ูˆ ุจุนุถ ุงู„ู…ุฑุงุช
561
00:46:28,080 --> 00:46:35,190
ุจูŠุตูŠุฑ ููŠู‡ deathู…ุงุดูŠ ูŠุจู‚ู‰ ุงูุฑุงุฒ ุงู„ IL-1 ูˆ ุงู„ human
562
00:46:35,190 --> 00:46:40,690
cross factor ุจูƒู…ูŠุฉ ูƒุจูŠุฑุฉ ู†ุชุฌุฉ ูˆุฌูˆุฏ ุงู†ุชุฌู† ุจูƒู…ูŠุฉ
563
00:46:40,690 --> 00:46:45,590
ูƒุจูŠุฑุฉ ูˆ ุชู†ุดูŠุท ุงู„ูŠู†ููˆุณุงูŠุช ุจูƒู…ูŠุฉ ูƒุจูŠุฑุฉ ุจูŠุคุฏูŠ ุฅู„ู‰
564
00:46:45,590 --> 00:46:50,030
ุงู„ู„ูŠ ู‡ูˆ toxic shock syndrome ุงู„ู„ูŠ ู…ู† ู…ุธุงู‡ุฑู‡ุง ุทุจุนุง
565
00:46:50,030 --> 00:46:53,430
fever ูˆ ุฒูŠ ู…ุง ู‚ู„ู†ุง ุฏู‡ ู‡ูˆ blood clotting diarrhea
566
00:46:53,430 --> 00:46:58,350
drop in blood pressure ูˆ shock ูˆ ู…ู…ูƒู† ุชุคุฏูŠ ุงู„ู‰
567
00:46:58,350 --> 00:47:03,470
ุงู„ูˆูุงุฉุญุงู„ุฉ ุงู„ู€ Bacterial Septic Shock ุฃูŠุถู‹ุง
568
00:47:03,470 --> 00:47:08,690
Overproduction of Cytokine ุงู„ู„ูŠ ุบุงู„ุจู‹ุง ุจุชูƒูˆู†
569
00:47:08,690 --> 00:47:12,010
ู…ุณุญูˆุจุฉ ููŠ ูˆุฌูˆุฏ Gram Negative Bacterial Infection
570
00:47:12,010 --> 00:47:18,970
ุฃูˆ Endotoxin produced by these bacteria ุจุชู†ุดุทู„ู†ุง
571
00:47:18,970 --> 00:47:24,530
ุงู„ู…ุงูƒุฑูˆูุงุฌ ูˆุจุงู„ุชุงู„ูŠ ุจุชูุฑุฒ IL-1 ูˆTumor Noxious
572
00:47:24,530 --> 00:47:29,740
Factor ุชูˆูŠ ุดูู†ุงู‡ู… Alphaุงู„ู„ูŠ ุจูŠู‚ุฏู‘ูˆ ุงู„ู‰ fatal form
573
00:47:29,740 --> 00:47:42,780
of bacterial septic shock ุญุงู„ุฉ
574
00:47:42,780 --> 00:47:50,300
ุงู„ cancer ููŠ ุญุงู„ุฉ ุงู„ cancer ุจูŠุตูŠุฑ
575
00:47:50,300 --> 00:47:56,020
ููŠู‡ ุทุจุนุง ุงูƒุชุฑ ู…ู† ุฎู„ุงูŠุง seboral lymphoid ูˆ myeloid
576
00:47:56,020 --> 00:47:56,520
cancer
577
00:47:59,730 --> 00:48:02,570
ุงู„ู„ูŠ are associated with abnormally high level of
578
00:48:02,570 --> 00:48:06,410
cytokine ูˆุจุงู„ุชุงู„ูŠ ุจูŠุตูŠุฑ ุจุฑุถู‡ cytokine receptor
579
00:48:06,410 --> 00:48:10,990
expression ุจูƒู…ูŠุงุช ูƒุจูŠุฑุฉ ูุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ุฃุถู„ T ุณู„ูˆ
580
00:48:10,990 --> 00:48:21,250
ูƒูŠู…ูŠุง ุบุงู„ุจุง ูŠูƒูˆู† ููŠู‡ุง T ุณู„ูˆ ุฃูˆ ู†ุชูŠุฌุฉ T ุณู„ูˆ ูƒูŠู…ูŠุง
581
00:48:21,250 --> 00:48:23,150
virus ุงู„ู„ูŠ ู‡ูˆ ุงู„ HDLV1
582
00:48:25,350 --> 00:48:33,530
ู‡ุฐู‡ ุงู„ููŠุฑูˆุณุงุช ูŠู…ูƒู†ู‡ุง ุงู†ููƒุงุฑ ุชู„ูŠู†ููˆุณุงูŠุช
583
00:48:33,530 --> 00:48:41,630
ูˆูˆุฌุฏุชู‡ุง ุจุชูุฑุฒ IL-2 ุจูƒู…ูŠุงุช ูƒุจูŠุฑุฉ ูˆ IL-2 ุฑูŠุณุจุชูˆุฑ ููŠ
584
00:48:41,630 --> 00:48:47,750
ุบูŠุงุจ ุงู„ุงู†ุชูŠุฌู† ู‡ุฐุง ุจูŠุคุฏูŠ ุงู„ู‰ autocrine stimulation
585
00:48:47,750 --> 00:48:52,750
of infected T cell ูˆุทุจุนุง ุจูŠุคุฏูŠ ุงู„ู‰ uncontrolled
586
00:48:52,750 --> 00:48:59,450
growthุจุฌูุนุงุช ุงู„ู€ T cell leukemia ุงู„ู„ูŠ ุทุจุนุง ู…ุณุจุจู‡ุง
587
00:48:59,450 --> 00:49:00,610
HTLV-1
588
00:49:05,050 --> 00:49:08,930
T lymphocyte is infected with this virus ูˆุจุงู„ุชุงู„ูŠ
589
00:49:08,930 --> 00:49:13,030
ุชูุฑุฒ ุงู„ IL-2 ุจูƒู…ูŠุงุช ูƒุจูŠุฑุฉ ูƒู…ุงู† ุงู„ receptor ุชุจุน ุงู„
590
00:49:13,030 --> 00:49:19,590
IL-2 ุจูŠูุฑุฒ ุจูƒู…ูŠุงุช ูƒุจูŠุฑุฉ ูˆุจุงู„ุชุงู„ูŠ ุจุชุชู†ุดุท ุงู„ู„ูŠ ู‡ูˆ ุงู„
591
00:49:19,590 --> 00:49:26,410
T lymphocyte ุนุฏุฏ ูƒุจูŠุฑ ู…ู† T lymphocyte ููŠ ุบูŠุงุจ ุงู„
592
00:49:26,410 --> 00:49:31,830
antigen ูˆ ู‡ุฐุง ุจูŠู‚ุฏูŠ ุงู„ autocrine stimulation
593
00:49:38,860 --> 00:49:43,300
ู…ุซุงู„ ุขุฎุฑ ู†ูŠูˆ ุจู„ุงุณุชูŠูƒ ุจูŠ ุณูŠู„ ูƒู…ูŠุฉ ูƒุจูŠุฑุฉ ุจูŠู†ู…ุง ูŠู†ุชุฌ
594
00:49:43,300 --> 00:49:49,680
ุณูƒุณ ู…ุซุงู„ ุขุฎุฑ ู‡ูˆุฏุฌูƒูŠู† ุฏูŠุฒูŠุฒ ูƒู…ูŠุฉ ูƒุจูŠุฑุฉ ู…ู† ุนูŠุงู„
595
00:49:49,680 --> 00:49:58,440
ููˆุงูŠู ุชู†ุชุฌ ููŠ ุงู„ auto immunity ูˆ ุงู„ disease ุงู„
596
00:49:58,440 --> 00:50:00,480
ุชูŠุฑูŠู†ููˆุณุงูŠุช
597
00:50:02,980 --> 00:50:10,680
ุฃุดุนุฑ ุจุงู„ุชุญูƒู… ุงู„ุชุญูƒู…ูŠ ู„ุฌูŠู„ุงุช ูˆุฌูŠู„ุงุช ุงู„ุงู†ุชูŠูˆุจูŠุง
598
00:50:10,680 --> 00:50:16,500
ูˆุงู„ุชุญูƒู… ููŠ ุงู„ุงู†ุชูŠูˆุจูŠุง.ุดูˆ
599
00:50:16,500 --> 00:50:23,760
ุจุชุนู…ู„ุŸ ุจุนุถู‡ุง ุจุณุจุจ ุญุฑูƒุฉ T-Hilbert-Cell.
600
00:50:28,980 --> 00:50:35,360
activation of T-Helper subset cell
601
00:50:35,360 --> 00:50:39,740
ูˆุจุงู„ุชุงู„ูŠ ุงู„ู€ cytokine ุงู„ู„ูŠ ุจุชูุฑุฒ ู…ู†ู‡ุง ุจู…ุง ููŠู‡ุง IL
602
00:50:39,740 --> 00:50:47,900
-10 ูˆ Gamma Interferon ูˆ IL-4 ูˆ several cytokine
603
00:50:47,900 --> 00:50:53,960
and cytokine receptor abnormality ุณุฌู„ุช are
604
00:50:53,960 --> 00:50:59,310
associated with autosystemic autoimmune diseaseุฒูŠ
605
00:50:59,310 --> 00:51:02,570
ุงู„ู€ SLE ูˆุจุฑู†ุงู…ุฌ autoimmune disease ุงู„ู„ูŠ ู„ุฌูˆุง ููŠู‡ุง
606
00:51:02,570 --> 00:51:07,090
ุนูŠุงู„ุชูŠู† ุจูƒู…ูŠุฉ ูƒุจูŠุฑุฉ ุงู„ู€ cytokine ุฃูŠุถุง ุชู„ุนุจ ุฏูˆุฑ
607
00:51:07,090 --> 00:51:10,610
ูƒุจูŠุฑ ููŠ ุงู„ pathophysiology ูˆุบุฐุฑ immune based
608
00:51:10,610 --> 00:51:14,190
disease ุจู…ุง ููŠู‡ุง ุงู„ุฃู„ุฑุฌูŠ ูˆุงู„ุฃุฒู…ุฉ ูˆinflammatory
609
00:51:14,190 --> 00:51:16,030
disease ุฒูŠ ุงู„ rheumatoid arthritis
610
00:51:21,420 --> 00:51:26,140
Therapeutic and diagnostic exploitation of
611
00:51:26,140 --> 00:51:31,040
cytokine and cytokine receptor ูƒูŠููŠุฉ ุงู„ุงุณุชูุงุฏุฉ
612
00:51:31,040 --> 00:51:36,880
ูˆุชุณุฎูŠุฑ ู‡ุฐู‡ ุงู„ุนู„ุงุฌุงุช ุชุณุฎูŠุฑ ู‡ุฐู‡ ุงู„ cytokine ูˆ ุงู„
613
00:51:36,880 --> 00:51:40,460
cytokine receptor ููŠ ู†ุงุญูŠุฉ ุนู„ุงุฌูŠุฉ cytokine
614
00:51:40,460 --> 00:51:44,140
inhibitor ุงูˆ antagonist ู‡ุฐู‡ ุงูˆู„ ุญุงุฌุฉ ูƒูŠู ู…ู…ูƒู† ู†ุนู…ู„
615
00:51:44,140 --> 00:51:49,300
ูˆู‚ู ุนู„ู‰ ุจุงู„ ุงู„ู„ูŠ ู‡ูˆ cytokine circulating soluble
616
00:51:49,300 --> 00:51:50,340
cytokine receptor
617
00:52:00,900 --> 00:52:04,640
ุจุงู„ุชุงู„ูŠ ู„ูˆ ุนู…ู„ู†ุง ู†ูŠูˆุชุฑุงู„ูŠุฒูŠุดู† ู„ู„ุงูƒุชููŠุฉ ู…ู† ู‡ุฐู‡ ุงู„ู€
618
00:52:04,640 --> 00:52:10,640
cytokine ุฃูˆ ุงู„ุฑูŠุณูŠุจุชูˆุฑ ู†ุนู…ู„ ุนู…ู„ูŠุฉ ุชูˆู‚ูŠู ู„ู†ุดุงุท ู‡ุฐุง
619
00:52:10,640 --> 00:52:14,660
ุงู„ู€ cytokine ุนู…ู„ูŠุฉ
620
00:52:14,660 --> 00:52:18,380
ุงุฑุชุจุงุท ุงู„ู€ cytokine ุจุงู„ุฑูŠุณูŠุจุชูˆุฑ ุชุจุนู‡ ู‡ูŠ ุนุจุงุฑุฉ ุนู†
621
00:52:18,380 --> 00:52:23,370
process specificูŠูˆู… ู…ุง ู†ุนู…ู„ neutralization ุฅู…ุง ู„ู„ู€
622
00:52:23,370 --> 00:52:27,150
cytokine ูˆุฅู…ุง ู„ู„ู€ receptor ู…ุงู†ุชูˆุง ุงุญู†ุง ุจู†ูˆู‚ู ุฑู‚ูŠุด
623
00:52:27,150 --> 00:52:32,450
ุนู…ู„ ู‡ุฐุง ุงู„ู€ cytokine ู…ุซุงู„ ุนู„ู‰ ุฐู„ูƒ these inhibitors
624
00:52:32,450 --> 00:52:35,870
ุงู„ู„ูŠ
625
00:52:35,870 --> 00:52:41,440
ุชุฑุชุจุท ุจุงู„ู€Ial-2ุŒ Ial-4ุŒ Ial-6ุŒ Ial-7ุŒ Gamma
626
00:52:41,440 --> 00:52:45,360
Interferon ูˆTumor Necrosis Factor.Tumor Necrosis
627
00:52:45,360 --> 00:52:49,640
Factor Inhibitor ุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ุชุณุชุฎุฏู… ููŠ ุงู„ู„ูŠ ู‡ูˆ
628
00:52:49,640 --> 00:52:55,280
ุนู„ุงุฌ ุฑูˆู…ุงุชูˆูŠุฏ ุฃุฑุซุฑุงุชูŠุฒ ู„ุฃู† ููŠ ุฑูˆู…ุงุชูˆูŠุฏ ุฃุฑุซุฑุงุชูŠุฒ ููŠ
629
00:52:55,280 --> 00:52:57,740
increase level of tumor necrosis factor Ial-1
630
00:52:57,740 --> 00:53:04,640
ู…ูˆุฌูˆุฏุฉ ููŠ ุงู„ joints Ial-1 Receptor Antagonist ุงู„ู„ูŠ
631
00:53:04,640 --> 00:53:09,330
ู‡ูˆุงู„ู€ Antagonist ู„ู„ู€ IL-1 ุฑูŠุณุจุชูˆุฑ ู…ุฑุชุจุท ุจุงู„ู€ IL-1
632
00:53:09,330 --> 00:53:13,770
ุฑูŠุณุจุชูˆุฑ ุงู„ู„ูŠ ู…ูˆุฌูˆุฏ ุนู„ู‰ ุณุทุญ ุงู„ู€ TCD4T-Lymphocyte
633
00:53:13,770 --> 00:53:19,110
ูˆุจุงู„ุชุงู„ูŠ ุจูŠุฑู†ุน ุงุฑุชุจุงุท ุงู„ู€ IL-1 ูˆุจุงู„ุชุงู„ูŠ ู…ุงููŠุด
634
00:53:19,110 --> 00:53:27,890
activation IL-1 Receptor Antagonist ุจูŠุณู…ูˆู‡ IL-1RA
635
00:53:27,890 --> 00:53:34,750
ูŠุนู†ูŠ Receptor AntagonistุจูŠุณุชุฎุฏู… ููŠ ุนู„ุงุฌ chronic
636
00:53:34,750 --> 00:53:40,090
inflammatory diseases ุงูŠุถุง we can ุงุณุชุฎุฏุงู… ุงู„
637
00:53:40,090 --> 00:53:43,770
inhibitor ูƒุนู„ุงุฌ
638
00:53:43,770 --> 00:53:50,390
ุงูŠุถุง we can reverse cellular deficiency ูŠุนู†ูŠ ูˆุงุญุฏ
639
00:53:50,390 --> 00:53:53,290
ุนู†ุฏู‡ neutropenia ุฒูŠ ู…ุง ุดูู†ุง ููŠ ุญุงู„ุฉ ุงู„
640
00:53:53,290 --> 00:53:58,120
chemotherapyุจูƒูŠู ุจุฏู†ุง ู†ุนู…ู„ู‡ุง reversing ุจู†ุจุฏูŠ
641
00:53:58,120 --> 00:54:04,400
cytokine ุชุญูุธ ุนู…ู„ูŠุฉ air ู„ growth of ุงู„ู„ูŠ ู‡ูˆ
642
00:54:04,400 --> 00:54:08,900
neutrophil ู‡ุฐุง ุจูŠุตูŠุฑ ููŠ ุญุงู„ุฉ ุงู„ chemotherapy
643
00:54:08,900 --> 00:54:15,780
ูˆูŠุฃู…ุซู„ ุนู„ู‰ ุฐู„ูƒ ุงู„ู„ูŠ ู‡ูˆ GCSF ูˆ GMCSF ุงูŠุถุง ููŠ
644
00:54:15,780 --> 00:54:20,760
ุงู…ูƒุงู†ูŠุฉ ุงู„ุงุณุชุบู„ุงู„ู‡ู… ููŠ ุนู„ุงุฌ ุงู„ immunodeficiency
645
00:54:22,310 --> 00:54:24,950
ู…ุซู„ู‹ุง ููŠ ุญุงู„ุฉ ุงู„ู€ X-linked A-Gamma-Globulinemia
646
00:54:24,950 --> 00:54:31,350
ู…ู…ูƒู† ุฃู† ูŠุนุงู„ุฌู‡ุง ุจุงู„ู€ G-CSF to reverse the
647
00:54:31,350 --> 00:54:36,150
neutropenia Gamma Interferon ุจูŠู‚ู„ู„ ู…ู† ุงู„ severity
648
00:54:36,150 --> 00:54:42,850
of infection ุบุงู„ุจู‹ุง ุจูˆุงุณุทุฉ ุฒูŠุงุฏุฉ ุงู„ู€ non-oxidative
649
00:54:42,850 --> 00:54:48,510
antimicrobial activity ุฃูŠุถู‹ุง treatment of cancer
650
00:54:48,510 --> 00:54:50,830
and transplanting
651
00:54:53,250 --> 00:54:57,630
ุงู„ุดุฎุต ุงู„ู„ุฐูŠ ูŠุชุนุงู…ู„ ู…ุน ู…ุฌุชู…ุน ุงู„ุงู†ูƒูŠุณูŠู„ ุฃูˆ
652
00:54:57,630 --> 00:55:03,550
ุชู„ูŠู†ููˆุณุงูŠุช ููŠูˆุฒูˆุฏ ูƒู…ูŠุงุช ูƒุจูŠุฑุฉ ู…ู† ุงู„ IL-2 ุชุคุฏูŠ ุฅู„ู‰
653
00:55:03,550 --> 00:55:08,790
ุชูƒูˆูŠู† ุงู„ุงู†ูƒุณูŠุณูŠู„ ุงู„ุงููƒุชูˆุฑูŠุงุช ุงู„ู„ูŠ ู‡ู… ู‚ูˆูŠุฉ ู„ุฏูŠู‡ุง
654
00:55:08,790 --> 00:55:09,290
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
655
00:55:09,290 --> 00:55:12,390
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
656
00:55:12,390 --> 00:55:13,550
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
657
00:55:13,550 --> 00:55:15,070
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
658
00:55:15,070 --> 00:55:16,030
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุน
659
00:55:16,340 --> 00:55:19,700
as it enhances the expression ูˆุนู…ู„ ุงู„ู€CGT2
660
00:55:19,700 --> 00:55:23,740
ู„ู„ู…ูˆู„ูŠูƒูŠูˆู„ ู…ุง ูŠุญุตู„ ู‡ูˆ ู†ุฃุฎุฐ ุฃู†ูƒุณูŠ ุงู„ุฃูˆุณุงุท
661
00:55:23,740 --> 00:55:28,280
ุงู„ุชูƒุณูƒุชูŠูŠู†ููˆุณุงุช ูˆู†ุนู…ู„ู‡ุง culture ููŠ ูˆุฌูˆุฏ IL-2 ูุจุตูŠุฑ
662
00:55:28,280 --> 00:55:34,420
ููŠ ูƒู…ูŠุงุช ูƒุจูŠุฑุฉ ู…ู† ุงู„ุฎู„ุงูŠุง ุงู„ู…ู†ุนูŠุฉ ุงู„ูุงุนู„ุฉ ู‡ุฐู‡ ูˆ
663
00:55:34,420 --> 00:55:39,200
these have potent antitumor activity ุงู„ู„ูŠ ุทุจุนุง ูŠูˆู…
664
00:55:39,200 --> 00:55:41,880
ู…ุง ุชุชู†ุดุท ุจูŠุตูŠุฑ ููŠู‡ ุฅูุฑุงุฒ ู„ู€Gamma Interferon ุนู„ู‰
665
00:55:41,880 --> 00:55:46,100
ุณุจูŠู„ ุงู„ู…ุซุงู„ ุฅูŠุดุŸ ูƒูŠู ุจูŠุดุชุบู„ุŸ
666
00:55:48,470 --> 00:55:53,850
ู‡ูˆ ุงู„ู€ Killing of Tumor Cell ูƒูŠูุŸ ู„ุฃู†ู‡ ุจูŠุฒูˆุฏ ุงู„
667
00:55:53,850 --> 00:55:57,210
expression of MHC Class II ู…ูˆู„ูŠูƒูŠูˆู„ ุนู„ู‰ ุณุทุญ
668
00:55:57,210 --> 00:56:02,730
ุงู„ุฎู„ุงูŠุง ุงู„ุณุฑูŠู†ุฉ Cytokine Receptor Specific
669
00:56:02,730 --> 00:56:08,270
Antibody ู…ู…ูƒู† ู†ุณุชุฎุฏู… ุงู„ู„ูŠ ู‡ูˆ antibody specific
670
00:56:08,270 --> 00:56:12,130
ู„cytokine receptor ู…ุนูŠู†
671
00:56:19,480 --> 00:56:25,940
ู…ุซุงู„ ุนู„ู‰ ุฐู„ูƒ ุงู† ู‚ุถู„ T cell leukemia lymphoma ATLL
672
00:56:25,940 --> 00:56:31,960
ุงู„ู„ูŠูˆูƒูŠู…ูŠูƒุณ ุงู„ ุงูƒุณุจูŠุณ ุงูŠุงู„ุชูˆ ุฑูŠุณุจุชูˆุฑ Alpha Chain
673
00:56:31,960 --> 00:56:39,100
ุจูˆ CD25 ูุงู„ูŠูˆู… ุจูŠุณุชุฎุฏู…ูˆุง ุงู„ entity Anti CD25
674
00:56:39,100 --> 00:56:45,720
Antibodyุทุจุนุง ู‡ุฐู‡ ุจุชุนู…ู„ Anti-Tag Antibody ุจูŠุณู…ูˆู‡ุง
675
00:56:45,720 --> 00:56:51,860
That induce response in one third of the patient
676
00:56:51,860 --> 00:56:56,260
ูŠุนู†ูŠ ุงู„ู…ู‡ู… ุฃุซุจุชุช ุฌุฏุงุฑุชู‡ุง ููŠ ุชู„ุช ุญุงู„ุงุช .. ุชู„ุช
677
00:56:56,260 --> 00:57:04,800
ุงู„ู…ุฑุถู‰ ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉAnti-T Anti-CD25 Therapy ุงู„ูŠูˆู…
678
00:57:04,800 --> 00:57:08,540
ุจูŠุณุชุฎุฏู… as part of regimen of immunosuppressive
679
00:57:08,540 --> 00:57:12,620
therapy ุจู†ุดูˆูู‡ุง ููŠ ูƒู„ ู…ุฑุถู‰ ุงู„ transplanted patient
680
00:57:12,620 --> 00:57:19,260
ุงู„ู„ูŠ ุจูŠุงุฎุฏูˆุง ูƒู†ูˆุน ู…ู† ุฃู†ูˆุงุน ุงู„ู„ูŠ ู‡ูˆ ุงู„ุชุซุจูŠุช ุงู„
681
00:57:19,260 --> 00:57:26,480
Allograft ุฃูˆ ุงู„ transplant rejection Treatment
682
00:57:26,480 --> 00:57:32,670
of allergy and asthmaุงู„ูŠูˆู… ุจุนู…ู„ ุงู†ุฌูŠูƒุดู† ู„ IL-4 ุดูˆ
683
00:57:32,670 --> 00:57:39,150
ุจุชุนู…ู„ IL-4ุŸ ุจุชูˆุนู‡ุง ุนุงู…ู„ุฉ class switching ู„ู€ B
684
00:57:39,150 --> 00:57:44,810
lymphocytes ูˆุจุงู„ุชุงู„ูŠ ุจุชุบูŠุฑ ู†ูˆุน ุงู„ antibody ุงู„ู„ูŠ
685
00:57:44,810 --> 00:57:50,110
ู…ุชูƒูˆู† ููŠ ุญุงู„ุฉ ุงู„ RIG ุจุชุบูŠุฑ ู…ู† ุงู„ IGE ู„ู„ IGG
686
00:57:52,720 --> 00:57:56,360
ุจุนุฏ ุฐู„ูƒ ูŠุฌุจ ุฃู† ุชุณุชุฎุฏู… ุงู„ู€ IL-4 ุฑูŠุณุจุชูˆุฑ ูˆ ู„ูŠุณ ูู‚ุท
687
00:57:56,360 --> 00:58:02,100
ุงู„ู€ IL-4 ุงู„ู€ cytokine ูƒู…ุงู† ุงู„ุฑูŠุณุจุชูˆุฑ ุชุจุนู‡ ูƒู…ุงู† ู„ุง
688
00:58:02,100 --> 00:58:09,260
ู†ู†ุณู‰ ุชูŠู‡ูŠู„ุจุฑ 17 ุชูŠ ุณูŠู„ ูˆ IL-17 ุงู„ู€ cytokine family
689
00:58:09,260 --> 00:58:17,800
ู…ุงุฐุง ุจุชุนู…ู„ุŸ ู‚ุงู„ูˆุง ู‡ุฐู‡ ุจุชุนู…ู„ filling the gap ูƒูŠูุŸ
690
00:58:17,800 --> 00:58:24,850
ู‚ุงู„ูˆุงุจุฅู…ูƒุงู†ู‡ู… ุฅุณุชุนู…ุงู„ ุฅุฌุงุฑุฉ ุงู„ุฅุฌุงุฑุฉ ุงู„ุฅูŠู…ูŠู†ูŠุฉ. ู…ุง
691
00:58:24,850 --> 00:58:27,870
ูŠูุนู„ IL-17ุŸ ุฌุงู„ู‡ Stimulate Demobilization and
692
00:58:27,870 --> 00:58:31,590
Generation of Neutrophil. ูˆุจุงู„ุชุงู„ูŠุŒ ูŠู‚ูˆู…ูˆุง ุจุฅุนุงุฏุฉ
693
00:58:31,590 --> 00:58:34,810
ุงู„ูุฑู‚ ุจูŠู† ุงู„ุฅุฌุงุฑุฉ ุงู„ุฅูŠู…ูŠู†ูŠุฉ ูˆุงู„ุฅุฌุงุฑุฉ ุงู„ุฅุฌุงุฑูŠุฉ
694
00:58:34,810 --> 00:58:44,230
ุงู„ุฅูŠู…ูŠู†ูŠุฉ. IL-17 ูŠุดุชุบู„ ููŠ ุญุงู„ุงุช ุงู„ุฅุฌุงุฑุฉ ุงู„ุฅูŠู…ูŠู†ูŠุฉ
695
00:58:44,230 --> 00:58:44,650
ูˆุงู„ุฅุฌุงุฑุฉ ุงู„ุฅูŠู…ูŠู†ูŠุฉ.
696
00:58:49,190 --> 00:58:53,070
ุงู„ู€ innate ูˆุงู„ู€ adaptive immune responses ุงูŠุถุง ุงู„ู€
697
00:58:53,070 --> 00:58:57,210
Tlbar-17 ุจุชู…ุซู„
698
00:58:57,210 --> 00:59:04,310
ุงู„ุฐุฑุงุน ุงู„ู€ adaptive immune response ูˆุจุชู…ุซู„
699
00:59:04,310 --> 00:59:07,970
ุทุจุนุง ุฐุฑุงุน ู‚ูˆูŠ in protection against extracellular
700
00:59:07,970 --> 00:59:16,480
bacteria and some fungi ูˆู‡ุฐู‡ ุจุนุถุงู„ุจุฑูƒุชูŠุฑูŠุง ุฃูˆ
701
00:59:16,480 --> 00:59:22,380
ุงู„ูู†ุฌุงูŠุง ุงู„ุชูŠ ุชุบุทูŠู‡ุง ุงู„ุจุฑูˆุงู†ูˆุชูŠุง ุงู„ุจุฑุชูˆู…ุง IL-17
702
00:59:22,380 --> 00:59:28,420
ุชุฏูุน ุชุญุฑูŠูƒ ุงู„ุชุญุฑูŠูƒ ูˆุงู„ุชุญุฑูŠูƒ ุงู„ู†ูˆุชุฑูˆููŠู„ ู†ูˆุชุฑูˆููŠู„
703
00:59:28,420 --> 00:59:33,400
ู†ูˆุชุฑูˆููŠู„ ู†ูˆุชุฑูˆููŠู„ ู†ูˆุชุฑูˆููŠู„ ู†ูˆุชุฑูˆููŠู„ ู†ูˆุชุฑูˆููŠู„
704
00:59:33,400 --> 00:59:38,680
ู†ูˆุชุฑูˆููŠู„
705
00:59:47,940 --> 00:59:58,540
ุจุงู„ุชุฃูƒูŠุฏ ุงู„ู€ K-Mediator ูŠุนุชุจุฑ ุงู„ู€ IL-17
706
00:59:58,540 --> 01:00:01,720
ู…ุฏูŠุฑ
707
01:00:01,720 --> 01:00:09,760
ู…ุฎุชู„ู ู…ู† ุงู„ู€ Auto-inflammatory cytokine ูˆุทุจุนุง
708
01:00:09,760 --> 01:00:17,350
ู‡ู†ุงุจูŠุจูŠู† ู„ู†ุง ุฏูˆุฑ ุฃูˆ ุงู„ุฎุทูˆุงุช ุงู„ู„ูŠ ุจุชูƒูˆู† ููŠู‡ุง ุงู„ู€
709
01:00:17,350 --> 01:00:25,490
neutrophil to induce its action ุทุจุนุง
710
01:00:25,490 --> 01:00:29,470
ู‡ุฐู‡ ุนุจุงุฑุฉ ุนู† ุฎุทูˆุงุช ุงู„ู€ phagocytosis ุฒูŠ ู…ุง ุงู†ุชูˆุง
711
01:00:29,470 --> 01:00:34,530
ุดุงูŠููŠู† ู‡ุฐู‡ ุนุจุงุฑุฉ ุนู† blood endothelial cells ุจุชุจุทู†
712
01:00:34,530 --> 01:00:38,170
ุฌุฏุงุฑ ุงู„ูˆุนูŠ ุงู„ุฏู…ูˆูŠููŠ ุงู„ูˆุถุน ุงู„ุทุจูŠุนูŠ ุงู„ู€ neutrophil
713
01:00:38,170 --> 01:00:44,270
is rolling ุนู„ู‰ ุณุทุญ ุงู„ endothelial cells once
714
01:00:44,270 --> 01:00:52,480
activated ูƒู…ุงู„ ูŠุงุฏูŠุฑุงู†ุณุฃูˆู„ ุฎุทูˆุฉ ู…ู† ุงู„ุฎุทูˆุงุช ุงู„ู„ูŠ ู‡ูˆ
715
01:00:52,480 --> 01:00:56,840
ุงู„ู€ phagocytosis ุซู… ุจุนุฏ ุฐู„ูƒ ุทุจุนุง ุงู„ adherence with
716
01:00:56,840 --> 01:01:00,040
adhesion molecule ุนู„ู‰ ุณุทุญ ุงู„ endothelial cell
717
01:01:00,040 --> 01:01:03,260
ุจุชุนู…ู„ activation ู„ู„ endothelial cell ูˆุจุงู„ุชุงู„ูŠ
718
01:01:03,260 --> 01:01:08,040
ุจูŠุตูŠุฑ ููŠู‡ ุชุจุงุนุฏ ุจูŠู† ุงู„ุฎู„ุงูŠุง ูุจุชุนู…ู„ Trans
719
01:01:08,040 --> 01:01:12,000
endothelial migration ุจุชุนู…ู„ Diabeteses ู‡ุฐู‡
720
01:01:12,000 --> 01:01:17,940
ุงู„ู†ูŠุชุฑุงููŠู„ ูˆุฏู‡ ู‡ูŠ ุทู„ุนุช ู…ู† ูˆูŠู† ู…ู† ุงู„ endothelial to
721
01:01:17,940 --> 01:01:23,030
the tissueูŠุนู†ูŠ Migration of Neutrophil ุซู… ุจุชุชุจุน
722
01:01:23,030 --> 01:01:27,890
ุงู„ู€ Chemotactic Factor Concentration Gradient ุฏู‡
723
01:01:27,890 --> 01:01:34,210
ู‡ูˆ ู…ุซุงู„ ุนู„ู‰ ุฐู„ูƒ ุงู„ู„ูŠ ู‡ูˆ ILA ูˆ ุจุชุจู‚ู‰ ู…ุงุดูŠุฉ ู„ุบุงูŠุฉ ู…ุง
724
01:01:34,210 --> 01:01:36,910
ุชุตู„ู…ูŠู† ู„ู„ Antigen
725
01:01:39,770 --> 01:01:45,390
ู‡ุฐุง ู…ุซุงู„ ุขุฎุฑ ุนู„ู‰ ุงู„ู€ Receptors ุจูŠุจูŠู† ู„ู†ุง ุงุฑุชุจุงุท
726
01:01:45,390 --> 01:01:50,370
ุงู„ู€ cytokine ุจุงู„ู€ Receptors with the affinity of
727
01:01:50,370 --> 01:01:54,510
cytokine receptor binding ุทุจุนุง ุญุณุจ ู†ูˆุน ุงู„ู€
728
01:01:54,510 --> 01:01:58,490
cytokine ุฅุฐุง ูƒุงู† double-chain ุฃูˆ triple-chain ุทุจุนุง
729
01:01:58,490 --> 01:02:03,690
ููŠ ุงู„ู€ double-chain ุจูŠูƒูˆู† affinity of bindingู…ู† ุงู„
730
01:02:03,690 --> 01:02:07,710
triple chain ู‡ูŠ ุงู†ุง intermediate affinity and high
731
01:02:07,710 --> 01:02:11,770
affinity ู„ุงู†ู‡ุง ุนูŠุด ู„ุงู†ู‡ุง triple chain ูˆ ุทุจุนุง ู‡ุฐุง
732
01:02:11,770 --> 01:02:18,970
ูู‚ุท ู…ุซุงู„ ุนู„ู‰ ุงู„ affinity or binding ู‡ูŠ ุงู†ุง ุนุดุฑุฉ
733
01:02:18,970 --> 01:02:24,130
ู‚ูˆุฉ minus ุชุณุนุฉ ุงู†ุง ุตุงุฑุช ุนุดุฑุฉ ู‚ูˆุฉ minus eleven ู„ุงู†
734
01:02:24,130 --> 01:02:30,650
ุงุชู†ุดุท ุทุจุนุง ุงู„ู„ูŠ ู‡ูˆ ุงู„ anky cell restingor resting
735
01:02:30,650 --> 01:02:36,510
T lymphocytes ุฃู†ุง ุตุงุฑ ููŠ activation ู„ T
736
01:02:36,510 --> 01:02:46,050
lymphocytes ุจู‡ูƒ ุจู†ูƒูˆู† ู…ุฑูŠู†ุง ุนู„ู‰ ุงู„ู…ุญุงุถุฑุฉ
737
01:02:46,050 --> 01:02:55,050
ูˆ ุฃุฎุฏู†ุง ุงู„ู„ูŠ ู‡ูˆ general view ุนู„ู‰ ุฐู„ูƒ